<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-03-28</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38539420/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">Impact of Targeted Agents on Survival of Chronic Lymphocytic Leukemia Patients Fit for Fludarabine, Cyclophosphamide, and Rituximab (FCR) Relative to Age- and Sex-Matched Population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38539420-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    To assess the impact of first-line treatment with targeted agents (TAs) or fludarabine, cyclophosphamide, and rituximab (FCR)-based chemo-immunotherapy (CIT) on overall survival (OS) compared to age- and sex-matched individuals in the general population, we conducted an aggregated analysis of phase 3 clinical trials, including the two FLAIR sub-studies, ECOG1912, and CLL13 trials. The restricted mean survival time (RMST), an alternative measure in outcome analyses capturing OS changes over &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38541169/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Sex Differences in Short- and Long-Term Survival after Acute Type A Aortic Dissection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38541169-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background and Objectives: Acute type A aortic dissection (AAD) is a life-threatening disease. No differences between men and women have been made in the treatment of AAD so far and knowledge about sex differences regarding long-term outcomes is limited. Materials and Methods: Between 01/2004 and 12/2021, 874 patients were operated on for AAD, including 313 (35.8%) women and 561 (64.2%) men. Clinical and surgical records, including long-term follow-up information, were obtained and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38541987/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Pleural Effusion and Chylothorax in Congenital Diaphragmatic Hernia-Risk Factors, Management and Outcome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38541987-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Pleural effusion and chylothorax are common complications in the treatment of congenital diaphragmatic hernia (CDH). We set out to identify risk factors for chylothorax development in patients with CDH and to investigate the association of pleural effusion and chylothorax with neonatal morbidity and mortality. Methods: In this retrospective cohort study, we included 396 neonates with CDH treated at our institution between January 2013 and June 2019. Preoperative and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542010/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Feasibility of Fluid Responsiveness Assessment in Patients at Risk for Increased Intracranial Pressure</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542010-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Effective fluid management is important for patients at risk of increased intracranial pressure (ICP). Maintaining constant cerebral perfusion represents a challenge, as both hypovolemia and fluid overload can severely impact patient outcomes. Fluid responsiveness tests, commonly used in critical care settings, are often deemed potentially hazardous for these patients due to the risk of disrupting cerebral perfusion. Methods: This single-center, prospective, clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542046/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Recalled Maternal Rearing Behaviour of Individuals Born Preterm and Their Mothers: The Impact of Intimate Mother-Child Contact</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542046-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Preterm birth is a risk factor for a variety of detrimental health outcomes. Previous studies have identified recalled (or remembered) parental rearing behaviour as a potential modifier of preterm individuals' mental health in adulthood. However, no investigations to date have contrasted the parents' and children&rsquo;s views, explored whether their congruence is associated with preterm individuals' mental health, or tested associations with maternal self-reported first &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542061/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Jozimine A&lt;sub&gt;2&lt;/sub&gt;, a Dimeric Naphthylisoquinoline (NIQ) Alkaloid, Shows In Vitro Cytotoxic Effects against Leukemia Cells through NF-ÎºB Inhibition</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542061-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Naphthylisoquinoline (NIQ) alkaloids are rising as a promising class of secondary metabolites with pharmaceutical potential. NF-ÎºB has already been recognized as a significant modulator of cancer proliferation and drug resistance. We have previously reported the mechanisms behind the cytotoxic effect of dioncophylline A, an NIQ monomer, in leukemia cells. In the current study, we have investigated the cytotoxic effect of jozimine A(2), an NIQ dimer, on leukemia cells in comparison to a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542193/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Peripheral Upregulation of Parkinson&#39;s Disease-Associated Genes Encoding Î±-Synuclein, Î²-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542193-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Due to the high comorbidity of Parkinson&rsquo;s disease (PD) with major depressive disorder (MDD) and the involvement of sphingolipids in both conditions, we investigated the peripheral expression levels of three primarily PD-associated genes: Î±-synuclein (SNCA), lysosomal enzyme Î²-glucocerebrosidase (GBA1), and UDP-glucose ceramide glucosyltransferase (UGCG) in a sex-balanced MDD cohort. Normalized gene expression was determined by quantitative PCR in patients suffering from MDD (unmedicated n = &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542253/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Renin-Angiotensin Inhibitor, Captopril, Attenuates Growth of Patient-Derived Colorectal Liver Metastasis Organoids</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542253-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The recurrence of colorectal liver metastasis (CRLM) following liver resection is common; approximately 40% of patients will experience tumor recurrence post-surgery. Renin-angiotensin inhibitors (RASis) have been shown to attenuate the growth and progression of CRLM in pre-clinical models following liver resection. This study examined the efficacy of the RASi captopril on patient-derived colorectal liver metastasis organoids. Patient-derived organoids (PDOs) were established using fresh &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542263/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Beyond Quiescent and Active: Intermediate Microglial Transcriptomic States in a Mouse Model of Down Syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542263-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Research on microglia in Down syndrome (DS) has shown that microglial activation, increased inflammatory gene expression, and oxidative stress occur at different ages in DS brains. However, most studies resulted in simplistic definitions of microglia as quiescent or active, ignoring potential intermediate states. Indeed, recent work on microglial cells in young DS brains indicated that those evolve through different intermediate activation phenotypes before reaching a fully activated state. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542409/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal Dysplasia and Cancer Screening-A Systematic Review and Meta-Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542409-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Elevated rates of human papillomavirus (HPV)-related anal high-grade squamous intraepithelial lesions (HSIL) and anal cancer (AC) in populations like men who have sex with men (MSM) living with HIV underscore the need for effective screening. While high-resolution anoscopy-guided biopsy is the gold standard, limited provider availability poses a challenge. This has spurred interest in identifying biomarkers for improved AC prevention. Antibodies against HPV16 oncoprotein E6, known as markers &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542718/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Serum 25-Hydroxyvitamin D Status and Vitamin D Supplements Use Are Not Associated with Low Back Pain in the Large UK Biobank Cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542718-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Longitudinal studies assessing the association of vitamin D deficiency, defined by serum 25-hydroxyvitamin D levels &lt; 30 nmol/L, and vitamin D supplement (VDS) use with low back pain (LBP) are sparse. This investigation assessed the cross-sectional and longitudinal association of vitamin D status and VDS use with LBP among 135,934 participants from the UK Biobank cohort. Approximately 21.6% of the participants had vitamin D deficiency, while only 4% regularly took VDS. In the month before &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38542750/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38542750-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Circulating 25-hydroxyvitamin D (25(OH)D) is the generally accepted indicator of vitamin D status. Since hydroxylation of 25(OH)D to 24-25-dihydroxyvitamin D (24,25(OH)2D) is the first step of its catabolism, it has been suggested that a low 24,25(OH)D level and a low vitamin D metabolite ratio (VMR), i.e., 24,25(OH)2D divided by 25(OH)D, may indicate high vitamin D requirements and provide additional diagnostic information beyond serum 25(OH)D. We, therefore, evaluated whether &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38543840/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">A New Inovirus from the Human Blood Encodes Proteins with Nuclear Subcellular Localization</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38543840-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Viruses infecting bacteria (bacteriophages) represent the most abundant viral particles in the human body. They participate in the control of the human-associated bacterial communities and play an important role in the dissemination of virulence genes. Here, we present the identification of a new filamentous single-stranded DNA phage of the family Inoviridae, named Ralstonia Inoviridae Phage 1 (RIP1), in the human blood. Metagenomics and PCR analyses detected the RIP1 genome in blood serum, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38544797/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: aÂ prospective cohort study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38544797-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Assessment of cardiovascular risk is critical for patients with cancer. Previous retrospective studies suggest potential cardiotoxicity of CAR T cell therapies. We aimed to prospectively assess cardiotoxicity and the predictive value of cardiac biomarkers and classical risk factors (age, cardiac function, diabetes, arterial hypertension, smoking) for cardiac events and all-cause mortality &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545806/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Parents&#39; Views on Prolonged Maternal Hospital Stay With Sick Newborn Infants in a Tertiary Neonatal Unit in Sri Lanka</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545806-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Mothers of infants in most Sri Lankan neonatal units are required to be &ldquo;inpatients&rdquo; during the entirety of their infant&rsquo;s stay. This traditional practice is closely aligned to the relatively newer model of family-integrated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545827/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545827-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Salivary duct carcinomas (SDC) of the parotid gland are rarely occurring highly malignant tumors. A 65-year-old man presented with a preauricular mass. After surgical treatment and histologic examination, the findings were interpreted as a squamous cell carcinoma (SCC) metastasis of the parotid gland deriving from a cancer of unknown primary DD primary SCC of the parotid gland. Adjuvant platinum-based radiochemotherapy was administered in domo. However, re-staging revealed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545829/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545829-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The data indicate that M1 metastases kill more patients in the first 2.5 years than between years 2.5 and 5 after diagnosis; T4 deaths are equal in the two periods, and in T3 mortality in the first 2.5-year period is lower than between years 2.5 and 5 after diagnosis. Conditional survival could be applied to explore critical survival periods even past 5 years after diagnoses and to monitor success in novel diagnostic and treatment practices. Improvement of survival in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545840/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545840-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our findings demonstrate the potential value of MerTK as a prognostic biomarker for gastric adenocarcinoma. Targeting MerTK may become a new treatment option, especially for patients with advanced tumors, and may overcome resistance to established &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38545850/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38545850-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546297/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Co-prevalence of arterial aneurysm location - a correlation analysis based on a retrospective cross-sectional observational study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546297-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The aim of this retrospective single-centre cross-sectional observational study was to investigate co-prevalence of arterial aneurysm location systematically. Patients and methods: Patients with the diagnosis of any arterial aneurysm from January 2006 to January 2016 were investigated in a single centre. Patients with hereditary disorders of connective tissue, systemic inflammatory disease, or arterial pathologies other than true aneurysms were excluded. Aneurysm locations &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546633/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">Zinzani PL, Thieblemont C, Melnichenko V, etÂ al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170. Blood. 2023;142(2):141-145</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546633-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546634/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">An unusual presentation of lymphoplasmacytic lymphoma with isolated brachial plexus infiltration and amyloidosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546634-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546635/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">AL amyloidosis response: a move in the &#34;light&#34; direction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546635-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546636/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">T-cell lymphoma: the CAR-T revolution is coming</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546636-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546637/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">GPR56 in GVL: marker or mechanism?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546637-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546638/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">TP53 function over forms in multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546638-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546639/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">Ironing erythroid cells takes FLG1 and ERFE to tango</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546639-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546640/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240328180643&amp;v=2.18.0.post9&#43;e462414">Sickle cell anemia: hepatic macrophages to the rescue</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546640-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240328180643-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38546696/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240328180704&amp;v=2.18.0.post9&#43;e462414">Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38546696-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240328180704-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There is little long-term outcome data on the efficacy of autologous hematopoietic stem cell transplantation (ASCT) in light chain deposition disease (LCDD). We identified 51 LCDD patients in the EBMT registry who had undergone upfront ASCT between 1995 and 2021. The median serum creatinine was 280 Î¼mol/L and 45% required renal replacement therapy (RRT) at time of transplant. The melphalan dose was 100mg/m2 in 23%, 140mg/m2 in 55% and 200 mg/m2 in 21%. The rate of very good partial response &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O73m8zH8R">HIVæ²»æ„ˆç ”ç©¶æœ€æ–°è¿›å±•ã€‚ä»Šå¤©Scienceä¸Šçº¿äº†ä¸€ç¯‡é‡è¦HIVæ²»æ„ˆæ–‡ç« ï¼Œè¿™å®é™…ä¸Šæ˜¯2020å¹´11æœˆNIH Strategies for HIV Cureä¼šè®®å·²ç»æŠ¥é“çš„æ•°æ®ï¼ˆç½‘é¡µé“¾æ¥ï¼‰ï¼Œå³N-803 &#43; 3B...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o73m8zh8r/">
    
    
    
    
    
      
    
    HIVæ²»æ„ˆç ”ç©¶æœ€æ–°è¿›å±•ã€‚ä»Šå¤©Scienceä¸Šçº¿äº†ä¸€ç¯‡é‡è¦HIVæ²»æ„ˆæ–‡ç« ï¼Œè¿™å®é™…ä¸Šæ˜¯2020å¹´11æœˆNIH Strategies for HIV Cureä¼šè®®å·²ç»æŠ¥é“çš„æ•°æ®ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼Œå³N-803 + 3BNC117 + 10-1074å¯ä»¥ä½¿åœæ­¢æŠ—ç—…æ¯’è¯åçš„æ’æ²³çŒ´ç—…æ¯’è½½é‡åå¼¹é€æ¸æ¶ˆå¤±ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->N-803ç”±Patrick Soon-Shiongï¼ˆé™ˆé¢‚é›„ï¼‰çš„ImmunityBioå…¬ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O74cyDmly">ä¸€äº›æœ‹å‹é—®ç¾å›½ç”Ÿç‰©åŒ»å­¦å·¥ä¸šç•Œæœ€è¿‘çš„å°±ä¸šæƒ…å†µã€‚æˆ‘åœ¨ç½®é¡¶å¾®åšè®²äº†ç”Ÿç‰©åŒ»å­¦PhDæ‰¾å·¥ä¸šç•Œå·¥ä½œçš„ä¸€äº›æ–¹æ³•ï¼ˆç½‘é¡µé“¾æ¥ï¼‰ï¼›ä½†æœ€è¿‘æˆ‘æ”¶åˆ°ä¸€äº›åé¦ˆï¼Œè®¤ä¸ºæœ€è¿‘ä¸€å¹´å·¦å³ï¼Œåœ¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o74cydmly/">
    
    
    
    
    
      
    
    ä¸€äº›æœ‹å‹é—®ç¾å›½ç”Ÿç‰©åŒ»å­¦å·¥ä¸šç•Œæœ€è¿‘çš„å°±ä¸šæƒ…å†µã€‚æˆ‘åœ¨ç½®é¡¶å¾®åšè®²äº†ç”Ÿç‰©åŒ»å­¦PhDæ‰¾å·¥ä¸šç•Œå·¥ä½œçš„ä¸€äº›æ–¹æ³•ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼›ä½†æœ€è¿‘æˆ‘æ”¶åˆ°ä¸€äº›åé¦ˆï¼Œè®¤ä¸ºæœ€è¿‘ä¸€å¹´å·¦å³ï¼Œåœ¨ç¾å›½æ‰¾health industryåŒ…æ‹¬biotechå’Œè¯å‚çš„å·¥ä½œå¼‚å¸¸è‰°éš¾ï¼Œå°¤å…¶æ˜¯æ²¡æœ‰ç»¿å¡çš„åŒå­¦æ‰¾è¿™äº›å·¥ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O75DJAvnI">ç‰¹åˆ«æ¨èä¸Šå‘¨å››NPRå†å²Podcast - ThroughlineèŠ‚ç›®å…³äºç¾å›½ç¦ä¹¦çš„ä¸€æœŸèŠ‚ç›®ï¼Œååˆ†ç²¾å½©ã€‚è¿™æœŸèŠ‚ç›®è§£è¯»äº†ç¾å›½æ„è¯†å½¢æ€æ•™è‚²çš„å†å²ã€‚æœ€è¿‘æˆ‘çœ‹äº†ä¸€ä¸ªå¯¹æŸä¸ªå›½å†…ç¬¬å…­ä»£å¯¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o75djavni/">
    
    
    
    
    
      
    
    ç‰¹åˆ«æ¨èä¸Šå‘¨å››NPRå†å²Podcast - ThroughlineèŠ‚ç›®å…³äºç¾å›½ç¦ä¹¦çš„ä¸€æœŸèŠ‚ç›®ï¼Œååˆ†ç²¾å½©ã€‚è¿™æœŸèŠ‚ç›®è§£è¯»äº†ç¾å›½æ„è¯†å½¢æ€æ•™è‚²çš„å†å²ã€‚æœ€è¿‘æˆ‘çœ‹äº†ä¸€ä¸ªå¯¹æŸä¸ªå›½å†…ç¬¬å…­ä»£å¯¼æ¼”çš„é‡‡è®¿ï¼Œä»–å¤§æ„è¯´ï¼Œæ¯ä¸ªå›½å®¶éƒ½ä¼šé™·å…¥è‡ªèº«çš„å†å²å¾ªç¯ï¼Œè¿™æºäºä¸€ä»£ä¸€ä»£ä¼ æ‰¿çš„æ•™è‚²å’Œç”±æ­¤å½¢æˆçš„æ°‘æ—æ€§æ ¼ã€‚ç¾å›½æœ‰å…¸å‹çš„å†å²å¾ªç¯ï¼Œè€Œç°åœ¨è®¸å¤šè’è¯ä¸ç»çš„ç°å®éƒ½å¯ä»¥åœ¨å†å²ä¸Šæ‰¾åˆ°ç±»ä¼¼çš„ç»å†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æ¯”å¦‚ç¦ä¹¦ã€‚è¿‡å»ä¸‰å¹´ï¼Œä½›ç½—é‡Œè¾¾å·é•¿Ron DeSantisä¸ºäº†è¿åˆç¾å›½æå³ç¿¼åŠ¿åŠ›ä»¥ç«é€‰æ€»ç»Ÿï¼Œåœ¨è¯¥å·å¼€å±•äº†å¤§é‡ç¦ä¹¦æ´»åŠ¨ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/O75rY5RzY">ç»™ç‚¹æç¤ºï¼Œä¸»è§’å¾ˆèƒ– - è½¬å‘ @åšé›†å¤©å·:&amp;ensp;[æŠ±ä¸€æŠ±]å™”å™”å™”ï¼Œå‰æ–¹ç¼–è¾‘ä¼ æ¥å°å‚è§†é¢‘ï¼å…¨ç½‘å‚¬æ›´çš„@é©¬ä¼¯åº¸ è€å¸ˆæ–°ä¹¦å·²ç»å¼€å§‹å°åˆ·äº†ï¼Œå¤§å®¶ä¸€èµ·ç§ç§æ˜¯å“ªæœ¬ä¹¦ï¼ˆç­”æ¡ˆè—...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-o75ry5rzy/">
    
    
    
    
    
      
    
    ç»™ç‚¹æç¤ºï¼Œä¸»è§’å¾ˆèƒ–<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åšé›†å¤©å·<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å™”å™”å™”ï¼Œå‰æ–¹ç¼–è¾‘ä¼ æ¥å°å‚è§†é¢‘ï¼<!-- raw HTML omitted --><!-- raw HTML omitted -->å…¨ç½‘å‚¬æ›´çš„<!-- raw HTML omitted -->@é©¬ä¼¯åº¸<!-- raw HTML omitted --> è€å¸ˆæ–°ä¹¦å·²ç»å¼€å§‹å°åˆ·äº†ï¼Œå¤§å®¶ä¸€èµ·ç§ç§æ˜¯å“ªæœ¬ä¹¦ï¼ˆç­”æ¡ˆè—åœ¨è§†é¢‘é‡Œï¼‰~<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[ä¸¾æ‰‹]&quot; src=&ldquo;<a href="https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/fd/2022_raisehand_org.png%22">https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/fd/2022_raisehand_org.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/O76DybUWe">é©¬å°çƒ¦æ˜¨å¤©ç»å†äº†äººç”Ÿç¬¬ä¸€æ¬¡çªç„¶çš„è¯€åˆ«ã€‚è¿˜å¥½ï¼Œä¸æ˜¯å’Œäººï¼Œä¹Ÿä¸æ˜¯å’Œå°åŠ¨ç‰©ï¼Œè€Œæ˜¯ä¸€å®¶æ—¥å¼æ‹‰é¢å°åº—ã€‚ä½†å¯¹ä»–æ¥è¯´ï¼Œä¼¤å¿ƒç¨‹åº¦å¹¶æ— ä¸åŒã€‚é©¬å°çƒ¦ä¸Šå°å­¦ä¹‹åï¼Œæˆ‘ä»¬æ¬åˆ°äº†...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-o76dybuwe/">
    
    
    
    
    
      
    
    é©¬å°çƒ¦æ˜¨å¤©ç»å†äº†äººç”Ÿç¬¬ä¸€æ¬¡çªç„¶çš„è¯€åˆ«ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿˜å¥½ï¼Œä¸æ˜¯å’Œäººï¼Œä¹Ÿä¸æ˜¯å’Œå°åŠ¨ç‰©ï¼Œè€Œæ˜¯ä¸€å®¶æ—¥å¼æ‹‰é¢å°åº—ã€‚ä½†å¯¹ä»–æ¥è¯´ï¼Œä¼¤å¿ƒç¨‹åº¦å¹¶æ— ä¸åŒã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->é©¬å°çƒ¦ä¸Šå°å­¦ä¹‹åï¼Œæˆ‘ä»¬æ¬åˆ°äº†ç°åœ¨ä½çš„å°åŒºã€‚è¿™ä¸ªå°åŒºå¯¹é¢æœ‰ä¸€ä¸ªå•†åœºï¼Œé‚£å®¶æ‹‰é¢åº—å°±åœ¨ä¸€å±‚ä¸´è¡—çš„ä½ç½®ï¼Œå‡ºäº†å°åŒºè¿‡é©¬è·¯å°±åˆ°ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘ä»¬ç¬¬ä¸€æ¬¡æ¥åƒï¼Œæ˜¯å› ä¸ºé©¬å°çƒ¦æŠ¥åäº†ä¸€å®¶è¶³çƒä¿±ä¹éƒ¨ï¼Œç¬¬ä¸€æ¬¡è®­ç»ƒå°±ç´¯å¾—è‡­æ­»ï¼Œé¥¥è‚ è¾˜è¾˜ï¼Œä»–å›å®¶ä¸€è·¯ä¸Šä¸åœåœ°å—·å—·å¾…å“ºã€‚å‡ºç§Ÿè½¦åœä¸‹çš„ä½ç½®ï¼Œæ°å¥½å°±åœ¨è¿™å®¶åº—é—¨å£ï¼Œå°ä¸œè¥¿ç´¯å¾—ä¸€æ­¥éƒ½ä¸è‚¯å¤šèµ°ï¼Œæˆ‘ä»¬å°±ç›´æ¥æ¨é—¨è¿›å»ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->å°åº—çš„è£…æ½¢æ²¡ä»€ä¹ˆç‰¹è‰²ï¼Œå±‹å­ä¹Ÿä¸å®½æ•ã€‚åº—é‡Œé™¤äº†å¯»å¸¸çš„è±šéª¨æˆ–å‘³å™Œæ‹‰é¢ä¹‹å¤–ï¼Œèœå•ä¸Šè¿˜æœ‰ä¸€æ¬¾é¸¡æ±¤ç›å‘³æ‹‰é¢ã€‚æ°å¥½æˆ‘åˆšè¯»åˆ°è´¾å¹³å‡¹å†™è€€å¿ç›æ±¤é¢çš„ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79IeCQMS">ğŸ”»ä¸€ä¸ªè¯•å›¾åœ¨ç§‘ç½—æ‹‰å¤šå·ä¼—è®®é™¢æ¨åŠ¨é€šè¿‡â€œè’‚äºšæ‹‰æ³•â€çš„ç»„ç»‡ã€‚è¯¥æ³•å¾‹å°†ä½¿å˜æ€§ç½ªçŠ¯æ›´å®¹æ˜“æ”¹åã€é€ƒé¿èº«ä»½è¯†åˆ«å’Œéšè—çŠ¯ç½ªè®°å½•ã€‚å®ƒä»¥å˜è£…çš‡åã€é‡ç½ªçŠ¯å’Œæ€§å·¥ä½œè€…è’‚äºš...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79iecqms/">
    
    
    
    
    
      
    
    ğŸ”»ä¸€ä¸ªè¯•å›¾åœ¨ç§‘ç½—æ‹‰å¤šå·ä¼—è®®é™¢æ¨åŠ¨é€šè¿‡â€œè’‚äºšæ‹‰æ³•â€çš„ç»„ç»‡ã€‚è¯¥æ³•å¾‹å°†ä½¿å˜æ€§ç½ªçŠ¯æ›´å®¹æ˜“æ”¹åã€é€ƒé¿èº«ä»½è¯†åˆ«å’Œéšè—çŠ¯ç½ªè®°å½•ã€‚å®ƒä»¥å˜è£…çš‡åã€é‡ç½ªçŠ¯å’Œæ€§å·¥ä½œè€…è’‚äºšæ‹‰çš„åå­—å‘½åã€‚<!-- raw HTML omitted -->ğŸ”»â€œç¾å›½æ–°è´¨ç”Ÿäº§åŠ›â€<!-- raw HTML omitted -->ğŸ”»æºï¼šlibsoftiktok <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79LPh69g">ğŸ”»æ³•å›½å‘è¨€äººç§°è”åˆå›½åœç«å†³è®®å…·æœ‰çº¦æŸåŠ›ï¼šâ€œæ ¹æ®å›½é™…æ³•ï¼Œè”åˆå›½å®‰å…¨ç†äº‹ä¼šçš„å†³è®®å…·æœ‰çº¦æŸåŠ›ã€‚æ‰€æœ‰æœ‰å…³å„æ–¹éƒ½å¿…é¡»æ‰§è¡Œè¯¥å†³è®®ï¼Œç‰¹åˆ«æ˜¯ä»¥è‰²åˆ—ï¼Œå®ƒæœ‰ä¹‰åŠ¡æ‰§è¡Œè¯¥å†³...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79lph69g/">
    
    
    
    
    
      
    
    ğŸ”»æ³•å›½å‘è¨€äººç§°è”åˆå›½åœç«å†³è®®å…·æœ‰çº¦æŸåŠ›ï¼šâ€œæ ¹æ®å›½é™…æ³•ï¼Œè”åˆå›½å®‰å…¨ç†äº‹ä¼šçš„å†³è®®å…·æœ‰çº¦æŸåŠ›ã€‚æ‰€æœ‰æœ‰å…³å„æ–¹éƒ½å¿…é¡»æ‰§è¡Œè¯¥å†³è®®ï¼Œç‰¹åˆ«æ˜¯ä»¥è‰²åˆ—ï¼Œå®ƒæœ‰ä¹‰åŠ¡æ‰§è¡Œè¯¥å†³è®®ã€‚â€<!-- raw HTML omitted -->ğŸ”»æºï¼šArnaud Bertrand<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å®‰ç†ä¼šé¦–æ¬¡é€šè¿‡æ˜ç¡®è¦æ±‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79O1wvq7">[æ€è€ƒ]ä¸ƒå¤©ä¹‹åå†æ¥çœ‹è®¢å•æ•°æ®ï¼Œå¯èƒ½æ¯”è¾ƒå‡†//@å°çš„32636:çœŸæœ‰äººä¿¡å•Šï¼Œå¼ºå¦‚ç‰¹æ–¯æ‹‰ä»Šå¹´ä¸€æœˆmodel y ä¹Ÿæ‰äº”ä¸‡è¾†ï¼Œå°ç±³åŠä¸ªå°æ—¶å°±äº”ä¸‡äº†?å°ç±³çš„è¥é”€ç­–ç•¥è¿˜æœ‰äººçœ‹ä¸æ˜...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79o1wvq7/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸ƒå¤©ä¹‹åå†æ¥çœ‹è®¢å•æ•°æ®ï¼Œå¯èƒ½æ¯”è¾ƒå‡†//<!-- raw HTML omitted -->@å°çš„32636<!-- raw HTML omitted -->:çœŸæœ‰äººä¿¡å•Šï¼Œå¼ºå¦‚ç‰¹æ–¯æ‹‰ä»Šå¹´ä¸€æœˆmodel y ä¹Ÿæ‰äº”ä¸‡è¾†ï¼Œå°ç±³åŠä¸ªå°æ—¶å°±äº”ä¸‡äº†?å°ç±³çš„è¥é”€ç­–ç•¥è¿˜æœ‰äººçœ‹ä¸æ˜ç™½å•Šï¼Œä»æ‰‹æœºå¼€å§‹ä¸€ç›´éƒ½è¿™æ ·<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79SE5UIB">ğŸ”»ä¿„å†› å  æœº æ–°è§†é¢‘ï¼Œçœ‹ç€åƒ Su-27ğŸ”»å¡ç“¦æ–¯æ‰˜æ³¢å°”æœ¬åœ°é¢‘é“è¯´ä¼˜å…ˆè€ƒè™‘æœºæ¢°æ•…éšœï¼Œå› ä¸ºæ²¡æœ‰çœ‹åˆ°é˜²ç©ºè¿è¡Œçš„è¿¹è±¡ã€‚ğŸ”»æºï¼šĞ§Ğ¿ / Ğ¡ĞµĞ²Ğ°ÑÑ‚Ğ¾Ğ¿Ğ¾Ğ»ÑŒ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79se5uib/">
    
    
    
    
    
      
    
    ğŸ”»ä¿„å†› å  æœº æ–°è§†é¢‘ï¼Œçœ‹ç€åƒ Su-27<!-- raw HTML omitted -->ğŸ”»å¡ç“¦æ–¯æ‰˜æ³¢å°”æœ¬åœ°é¢‘é“è¯´ä¼˜å…ˆè€ƒè™‘æœºæ¢°æ•…éšœï¼Œå› ä¸ºæ²¡æœ‰çœ‹åˆ°é˜²ç©ºè¿è¡Œçš„è¿¹è±¡ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šĞ§Ğ¿ / Ğ¡ĞµĞ²Ğ°ÑÑ‚Ğ¾Ğ¿Ğ¾Ğ»ÑŒ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/sG4hoVMOlx08dEgQthtC010412004kTd0E0">https://f.video.weibocdn.com/o0/sG4hoVMOlx08dEgQthtC010412004kTd0E0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79W1DdYS">ğŸ”»æˆ‘è¦å‘ä½ ä»¬ä»‹ç»åœŸä¾„ä»¬çš„â€œè‡ªç”±ä¸»ä¹‰æ•‘ä¸–ä¸»â€ï¼šé˜¿æ ¹å»·æ€»ç»Ÿç±³è±è¯´ï¼Œâ€œä»¥è‰²åˆ—æ²¡æœ‰ä»»ä½•è¿‡æ¿€è¡Œä¸ºã€‚â€ğŸ”»æºï¼šCNN åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79w1ddys/">
    
    
    
    
    
      
    
    ğŸ”»æˆ‘è¦å‘ä½ ä»¬ä»‹ç»åœŸä¾„ä»¬çš„â€œè‡ªç”±ä¸»ä¹‰æ•‘ä¸–ä¸»â€ï¼šé˜¿æ ¹å»·æ€»ç»Ÿç±³è±è¯´ï¼Œâ€œä»¥è‰²åˆ—æ²¡æœ‰ä»»ä½•è¿‡æ¿€è¡Œä¸ºã€‚â€<!-- raw HTML omitted -->ğŸ”»æºï¼šCNN <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.we">https://f.video.we</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O79XjxZll">ğŸ”»[å“†å•¦Aæ¢¦åƒæƒŠ]#å°ç±³SU7ä»·æ ¼# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o79xjxzll/">
    
    
    
    
    
      
    
    ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å°ç±³SU7ä»·æ ¼#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7a9Mnq20">ğŸ”»åˆ·äº†ä¸€åœˆä¸»é¡µï¼Œæˆ‘å‘ç°è¯´â€œä»Šå¹´ä¸ä¹°è½¦â€çš„æˆ‘è·Ÿé¦–é¡µæ˜¾å¾—æœ‰ç‚¹æ ¼æ ¼ä¸å…¥â€¦â€¦#å°ç±³SU7ä»·æ ¼#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7a9mnq20/">
    
    
    
    
    
      
    
    ğŸ”»åˆ·äº†ä¸€åœˆä¸»é¡µï¼Œæˆ‘å‘ç°è¯´â€œä»Šå¹´ä¸ä¹°è½¦â€çš„æˆ‘è·Ÿé¦–é¡µæ˜¾å¾—æœ‰ç‚¹æ ¼æ ¼ä¸å…¥â€¦â€¦<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å°ç±³SU7ä»·æ ¼#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7adfhfTP">ğŸ”»é¦–é¡µéƒ½åœ¨ä¸Šé¡¶é…ï¼Œç„¶åè¿™æ¡ä¹Ÿå¤¹åœ¨çƒ­æœé‡Œã€‚ğŸ”»ä¸Šç½‘åŸºæ•°è¿˜æ˜¯å¤ªå¤§äº†ã€‚#å­˜æ¬¾åˆ°10ä¸‡æ˜¯ä»€ä¹ˆæ„Ÿè§‰# [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7adfhftp/">
    
    
    
    
    
      
    
    ğŸ”»é¦–é¡µéƒ½åœ¨ä¸Šé¡¶é…ï¼Œç„¶åè¿™æ¡ä¹Ÿå¤¹åœ¨çƒ­æœé‡Œã€‚<!-- raw HTML omitted -->ğŸ”»ä¸Šç½‘åŸºæ•°è¿˜æ˜¯å¤ªå¤§äº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å­˜æ¬¾åˆ°10ä¸‡æ˜¯ä»€ä¹ˆæ„Ÿè§‰#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7aEq9WnX">ğŸ”»ç¡å‰çœ‹äº†ä¸‹é™ˆå¿—æ–°è€å¸ˆçš„ç¤¾ä¼šç§‘å­¦æ¦‚è®ºï¼Œç‚¹å¼€ç¬¬ä¸€è®²ï¼Œå‡Œæ™¨2ç‚¹åŠè¿˜æœ‰1000å¤šäººåœ¨çº¿çœ‹ï¼Œç¬¬äºŒè®²æœ‰741ä¸ªäººæ­£åœ¨çœ‹ã€‚ğŸ”»é™ˆè€å¸ˆç°åœ¨æœ‰71ä¸‡ç²‰ä¸ï¼Œç¬¬ä¸€è®²çš„åºè¨€æ˜¯å…¨ç«™çƒ­...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7aeq9wnx/">
    
    
    
    
    
      
    
    ğŸ”»ç¡å‰çœ‹äº†ä¸‹é™ˆå¿—æ–°è€å¸ˆçš„ç¤¾ä¼šç§‘å­¦æ¦‚è®ºï¼Œç‚¹å¼€ç¬¬ä¸€è®²ï¼Œå‡Œæ™¨2ç‚¹åŠè¿˜æœ‰1000å¤šäººåœ¨çº¿çœ‹ï¼Œç¬¬äºŒè®²æœ‰741ä¸ªäººæ­£åœ¨çœ‹ã€‚<!-- raw HTML omitted -->ğŸ”»é™ˆè€å¸ˆç°åœ¨æœ‰71ä¸‡ç²‰ä¸ï¼Œç¬¬ä¸€è®²çš„åºè¨€æ˜¯å…¨ç«™çƒ­åº¦ç¬¬ä¸€ã€‚<!-- raw HTML omitted -->ğŸ”»éšä¾¿å¹³æ—¶æ€ä¹ˆè°ƒä¾ƒç”œç«™ï¼Œæœ‰è¿™ä¹ˆå¤šäººæ„¿æ„è®¤è®¤çœŸçœŸçœ‹è€å¸ˆè®¤è®¤çœŸçœŸè®²çš„è¯¾ï¼ŒçœŸçš„å¾ˆé«˜å…´ã€‚<!-- raw HTML omitted -->ğŸ”»æ™šå®‰ã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%AF%BE%23&amp;amp;extparam=%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%25A">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%AF%BE%23&amp;amp;extparam=%23B%E7%AB%99%E5%9B%9E%E5%BA%94%E5%8C%97%E5%B8%88%E5%A4%A7%E6%95%99%E6%8E%88%E5%8F%91%E4%BC%A0%E5%8D%95%E6%8E%A8%E8%8D%90%E5%85%8D%E8%B4%B9%E8%A</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O7aiqt9YK">ğŸ”»ä¸æ­¤åŒæ—¶ï¼Œçœ‹çœ‹ tiktok ä¸Šçš„ç¾å›½å°è§†é¢‘ï¼šâ€œæˆ‘å…¬å¸åŒäº‹ä¹°è½¦çš„æƒ…å†µï¼Œä»¥åŠæ¯ä¸ªæœˆçš„è½¦è´·ã€‚â€ğŸ”»è€ƒè™‘åˆ°ä»–ä»¬éƒ½æ˜¯ä¸ºé“å¥‡ç»é”€å•†å·¥ä½œï¼Œä½œä¸ºå‘˜å·¥å¯ä»¥äº«å—æŠ˜æ‰£ä»¥åŠæ¯”è¾ƒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o7aiqt9yk/">
    
    
    
    
    
      
    
    ğŸ”»ä¸æ­¤åŒæ—¶ï¼Œçœ‹çœ‹ tiktok ä¸Šçš„ç¾å›½å°è§†é¢‘ï¼šâ€œæˆ‘å…¬å¸åŒäº‹ä¹°è½¦çš„æƒ…å†µï¼Œä»¥åŠæ¯ä¸ªæœˆçš„è½¦è´·ã€‚â€<!-- raw HTML omitted -->ğŸ”»è€ƒè™‘åˆ°ä»–ä»¬éƒ½æ˜¯ä¸ºé“å¥‡ç»é”€å•†å·¥ä½œï¼Œä½œä¸ºå‘˜å·¥å¯ä»¥äº«å—æŠ˜æ‰£ä»¥åŠæ¯”è¾ƒå¥½çš„è½¦è´·è®¡åˆ’ï¼Œä½†æ™®é€šå¸‚æ°‘å¾ˆéš¾è´Ÿæ‹…æ›´é«˜çš„è½¦æ¬¾ã€‚<!-- raw HTML omitted -->ğŸ”»æ„Ÿè§‰å’Œä¸­å›½çš„è´­è½¦ç°çŠ¶å·²ç»æ˜¯ä¸¤ä¸ªä¸–ç•Œé—´çš„æ¯”è¾ƒäº†ã€‚<!-- raw HTML omitted -->ğŸ”»æœˆä¾› 1298 ç¾å…ƒè´­ä¹°ä¸€è¾† Jeepâ€¦â€¦<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å°ç±³SU7ä»·æ ¼#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/O76ngrNhg">æ¥å®Œç”µè¯æ„¤æ€’çš„æŠŠå‰å‰è€æ¿çš„å¤‡æ³¨æ”¹æˆäº†è€ç™»[æ€’]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-o76ngrnhg/">
    
    
    
    
    
      
    
    æ¥å®Œç”µè¯æ„¤æ€’çš„æŠŠå‰å‰è€æ¿çš„å¤‡æ³¨æ”¹æˆäº†è€ç™»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O757OoetW">é‡æ¸©è€å­µè›‹ç”Ÿæ´» [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o757ooetw/">
    
    
    
    
    
      
    
    é‡æ¸©è€å­µè›‹ç”Ÿæ´» <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O76MBkdcZ">//@é¡¶ç­†TENä½¿:ä¹…ä¿å²ç»ªé‡Œ - è½¬å‘ @ä¹ƒæœ¨å‚46:&amp;ensp;ğŸ“¸#ä¹ƒæœ¨å‚46GALLERY#ğŸ“¸[æŠ±ä¸€æŠ±]#3æœŸç”Ÿ# Works[æŠ±ä¸€æŠ±]ä¹ƒæœ¨å‚46 #æ¢…æ³½ç¾æ³¢# #ä¹…ä¿å²ç»ªé‡Œ# #ä½è—¤æ«# #å‘äº•å¶...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o76mbkdcz/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ä¹ƒæœ¨å‚46<!-- raw HTML omitted -->:â€‚ğŸ“¸&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?contai">https://m.weibo.cn/search?contai</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O76MwhIAW">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.mdrp part.1 [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o76mwhiaw/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.1 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t1dfcjcj318g0tl47w.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t1dfcjcj318g0tl47w.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O76MxAgYV">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.mdrp part.2 [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o76mxagyv/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.2 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3msxkvj318g0tl157.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3msxkvj318g0tl157.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O77Sbjk5Y">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.BUBKA_henshuubu é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o77sbjk5y/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O77SMl2WT">å›°å¾—å¾ˆè¹Šè··</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o77sml2wt/">
    
    
    
    
    
      
    
    å›°å¾—å¾ˆè¹Šè··  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O7800eCFM">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.BUBKA_henshuubu [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o7800ecfm/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6ydi5rakj323v35s4qp.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6ydi5rakj323v35s4qp.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79YkFoHp">è½¬å‘å¾®åš - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ#å±±ä¸‹ç¾æœˆæ‰‹æœºåš# 240328.1ã€Œè¿Ÿäº†å±±ã€è¿Ÿäº†å±±å›°å¾—æœ‰ç‚¹å‰å®³ä¸€ä¸ªä¸æ³¨æ„åˆšæ‰æ‰‹æœºç ¸è„¸ä¸Šäº†å¾ˆç–¼çš„é‚£ç§å‘¢æƒ³ç€å±±ä¸‹çš„å›°å€¦...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79ykfohp/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79Zbgl0V">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.seventeen å®˜ç½‘ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79zbgl0v/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeen å®˜ç½‘ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho73apm0brj30ku0rsdjg.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho73apm0brj30ku0rsdjg.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79ZemrCX">å‡å¤© - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡ŒBUBKA 5æœˆå· part.1â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79zemrcx/">
    
    
    
    
    
      
    
    å‡å¤©<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5æœˆå· part.1<!-- raw HTML omitted -->â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»<!-- raw HTML omitted -->â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho74d">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho74d</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O79ZqC79h">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡ŒBUBKA 5æœˆå· part.2â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o79zqc79h/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5æœˆå· part.2<!-- raw HTML omitted -->â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»<!-- raw HTML omitted -->â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1h">https://tvax1.sinaimg.cn/large/006z6nxLgy1h</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O74kIoFuj">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨æ‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o74kiofuj/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨æ‹ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6cyyl99zj30xc18g4d6.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6cyyl99zj30xc18g4d6.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O76y9dhpr">æœŸå¾…ä¹…ä¿çš„é¹½éºµåŒ…é£Ÿè­œ[å“ˆå“ˆ][äºŒå“ˆ] [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o76y9dhpr/">
    
    
    
    
    
      
    
    æœŸå¾…ä¹…ä¿çš„é¹½éºµåŒ…é£Ÿè­œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/005TCz76gy1ho6s2ic8nej31gc0u0wjl.jpg%22">https://tvax4.sinaimg.cn/large/005TCz76gy1ho6s2ic8nej31gc0u0wjl.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O77jtBefN">å¶åƒæ‰‹ä½œéºµåŒ… [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o77jtbefn/">
    
    
    
    
    
      
    
    å¶åƒæ‰‹ä½œéºµåŒ… <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O77TLAtCm">è½‰ç™¼å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.BUBKA_henshuubu é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o77tlatcm/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O77TW664R">åˆ†äº«å›¾ç‰‡ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o77tw664r/">
    
    
    
    
    
      
    
    åˆ†äº«å›¾ç‰‡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O78E54sIM">å°è™ç‰™[å“ˆå“ˆ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o78e54sim/">
    
    
    
    
    
      
    
    å°è™ç‰™<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O78MfEmh4">ç¸½è¦ºå¾—ä¹…ä¿åœ¨æ‹17ç…§ç‰‡æ™‚å¾ˆç´¯ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o78mfemh4/">
    
    
    
    
    
      
    
    ç¸½è¦ºå¾—ä¹…ä¿åœ¨æ‹17ç…§ç‰‡æ™‚å¾ˆç´¯ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O79n8nIWH">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡ŒBUBKA 5æœˆå· part.1â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o79n8niwh/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5æœˆå· part.1<!-- raw HTML omitted -->â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»<!-- raw HTML omitted -->â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho7">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho7</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O79norKbb">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡ŒBUBKA 5æœˆå· part.2â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o79norkbb/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5æœˆå· part.2<!-- raw HTML omitted -->â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»<!-- raw HTML omitted -->â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1h">https://tvax1.sinaimg.cn/large/006z6nxLgy1h</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O73xod3RN">æ£‹æ‰‹æˆ˜é¹°è¯´å®è¯æˆ‘è¿˜çœŸæƒ³çœ‹çœ‹é¹°å­æ€ä¹ˆcosä¿å¦¹å¦¹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o73xod3rn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¯´å®è¯æˆ‘è¿˜çœŸæƒ³çœ‹çœ‹é¹°å­æ€ä¹ˆcosä¿å¦¹å¦¹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O74lxn1jT">æ—¥æœ¬æ£‹é™¢åœ¨ä»Šå¹´7æœˆ17æ—¥è¿æ¥åˆ›ç«‹100å‘¨å¹´ï¼Œæˆ‘æ‰“ç®—ä»4æœˆ1æ—¥å¼€å§‹é€æ­¥æ›´æ–°ä¸€ä¸‹æ—¥æœ¬æ£‹é™¢çš„100å‘¨å¹´çºªå¿µè¿è½½æœ‰è¿™ä¸¤ä¸ªè¿è½½Â· 100åæ£‹æ‰‹çš„â€œä»¤æˆ‘å°è±¡æ·±åˆ»çš„ä¸€æ‰‹æ£‹â€Â· æ—¥æœ¬...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o74lxn1jt/">
    
    
    
    
    
      
    
    æ—¥æœ¬æ£‹é™¢åœ¨ä»Šå¹´7æœˆ17æ—¥è¿æ¥åˆ›ç«‹100å‘¨å¹´ï¼Œæˆ‘æ‰“ç®—ä»4æœˆ1æ—¥å¼€å§‹é€æ­¥æ›´æ–°ä¸€ä¸‹æ—¥æœ¬æ£‹é™¢çš„100å‘¨å¹´çºªå¿µè¿è½½<!-- raw HTML omitted --><!-- raw HTML omitted -->æœ‰è¿™ä¸¤ä¸ªè¿è½½<!-- raw HTML omitted -->Â· 100åæ£‹æ‰‹çš„â€œä»¤æˆ‘å°è±¡æ·±åˆ»çš„ä¸€æ‰‹æ£‹â€<!-- raw HTML omitted -->Â· æ—¥æœ¬å›´æ£‹ç™¾å¤§å¥ åŸºäºº<!-- raw HTML omitted -->å—¯ï¼Œå¤šå†™200ç¯‡ä¸œè¥¿ï¼Œè¿˜å¥½ä¹Ÿä¸ç®—å¤ªé•¿<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸éš¾å¦è®¤æˆ‘å¿ƒä¸­çš„æŸä¸ªè§’è½ä¼šè¯´ï¼šâ€œä½ ç‰¹ä¹ˆåˆç»™è‡ªå·±æ·»éº»çƒ¦â€ï¼Œä¸è¿‡è€ƒè™‘åˆ°æ—¥æœ¬æ£‹é™¢110å‘¨å¹´çš„æ—¶å€™ï¼Œæˆ–è®¸ä¸ä¼šæœ‰è¿™ä¹ˆå¤§çš„è¿è½½ã€‚ä¸å…¶ä¸å†™è®©æˆ‘ç•™ä¸‹é—æ†¾ï¼Œä¸å¦‚å…ˆç¿»äº†å†è¯´ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%9B%B4%E6%A3%8B&amp;amp;containerid=10080864408f17859127e">https://m.weibo.cn/p/index?extparam=%E5%9B%B4%E6%A3%8B&amp;amp;containerid=10080864408f17859127e</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O77Tit3Kh">æ£‹æ‰‹æˆ˜é¹° è¿™è„¸æ€ä¹ˆï¼Œå¤§äº†ä¸€åœˆï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o77tit3kh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™è„¸æ€ä¹ˆï¼Œå¤§äº†ä¸€åœˆï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O79m5sIBA">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä»AlphaGoçš„â€œ1è´¥â€æ•æ‰äººç±»ç”Ÿå­˜ç­–ç•¥ã€‹ #å›´æ£‹# å›´æ£‹ ä»AlphaGoçš„â€œ1è´¥â€æ•æ‰äººç±»ç”Ÿå­˜ç­–ç•¥ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o79m5siba/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä»AlphaGoçš„â€œ1è´¥â€æ•æ‰äººç±»ç”Ÿå­˜ç­–ç•¥ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O75Jmfh6p">ä¹…ä¿å²ç»ªé‡Œ via.kaiki_rupo4æœˆ4æ—¥ï¼ˆå‘¨å››ï¼‰å¼€å§‹æ¯å‘¨25ç‚¹ï¼ˆJSTï¼‰ï¼Œå…¨å…­å›åˆå›MCï¼šä½ä¹…é–“å®£è¡Œå˜‰å®¾ï¼šå‘‚å¸ƒã‚«ãƒ«ãƒ/è“®è¦‹ç¿”ï¼ˆãƒ€ã‚¦90000ï¼‰/ä¹…ä¿å²ç»ªé‡Œï¼ˆä¹ƒæœ¨å‚46ï¼‰ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o75jmfh6p/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.kaiki_rupo<!-- raw HTML omitted -->4æœˆ4æ—¥ï¼ˆå‘¨å››ï¼‰å¼€å§‹æ¯å‘¨25ç‚¹ï¼ˆJSTï¼‰ï¼Œå…¨å…­å›<!-- raw HTML omitted -->åˆå›<!-- raw HTML omitted -->MCï¼šä½ä¹…é–“å®£è¡Œ<!-- raw HTML omitted -->å˜‰å®¾ï¼šå‘‚å¸ƒã‚«ãƒ«ãƒ/è“®è¦‹ç¿”ï¼ˆãƒ€ã‚¦90000ï¼‰/<!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œï¼ˆä¹ƒæœ¨å‚46ï¼‰ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy">https://tvax2.sinaimg.cn/large/006z6nxLgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O76LwbfhG">ä¹…ä¿å²ç»ªé‡Œvia.mdrp part.1 [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o76lwbfhg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.1 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6t1e1901">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6t1e1901</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O76M54uaY">ä¹…ä¿å²ç»ªé‡Œvia.mdrp part.2 [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o76m54uay/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.mdrp part.2 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3n8sc4">https://tvax2.sinaimg.cn/large/006z6nxLgy1ho6t3n8sc4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O76M9lrhc">ä¹…ä¿å²ç»ªé‡Œ - è½¬å‘ @ä¹ƒæœ¨å‚46:&amp;ensp;ğŸ“¸#ä¹ƒæœ¨å‚46GALLERY#ğŸ“¸[æŠ±ä¸€æŠ±]#3æœŸç”Ÿ# Works[æŠ±ä¸€æŠ±]ä¹ƒæœ¨å‚46 #æ¢…æ³½ç¾æ³¢# #ä¹…ä¿å²ç»ªé‡Œ# #ä½è—¤æ«# #å‘äº•å¶æœˆ# [å›¾ç‰‡][å›¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o76m9lrhc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ä¹ƒæœ¨å‚46<!-- raw HTML omitted -->:â€‚ğŸ“¸&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O77O0xHA8">ä¹…ä¿å²ç»ªé‡Œvia.BUBKA_henshuubu é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o77o0xha8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25">https://h5.sinaimg.cn/upload/2015/09/25</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O77Y7nCN3">ä¹…ä¿å²ç»ªé‡Œvia.BUBKA_henshuubu [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o77y7ncn3/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.BUBKA_henshuubu <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6y">https://tvax3.sinaimg.cn/large/006z6nxLgy1ho6y</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O795fmBpi">ä¹…ä¿å²ç»ªé‡Œvia.seventeen å®˜ç½‘ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o795fmbpi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeen å®˜ç½‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1ho73ap">https://tvax1.sinaimg.cn/large/006z6nxLgy1ho73ap</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O79kCjf2I">ä¹…ä¿å²ç»ªé‡ŒBUBKA 5æœˆå· part.2â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o79kcjf2i/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5æœˆå· part.2<!-- raw HTML omitted -->â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»<!-- raw HTML omitted -->â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O79kjnqi4">ä¹…ä¿å²ç»ªé‡ŒBUBKA 5æœˆå· part.1â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o79kjnqi4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->BUBKA 5æœˆå· part.1<!-- raw HTML omitted -->â€»ç»„å†…è‡ªè´­ è¯·å‹¿å¤–ä¼ â€»<!-- raw HTML omitted -->â€»ç„¡æ–­è»¢è¼‰ãŠæ–­ã‚Šâ€» <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sin">https://tvax2.sin</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O7aDJ9c1U">ä¹…ä¿å²ç»ªé‡Œbubkaæ‹¼é¡µ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o7adj9c1u/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->bubkaæ‹¼é¡µ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O78H5shUv">æŸ¯æ´#é›…å±…ä¹æ¸…æ°´æ¹¾æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›äº‹æŠ¥é“#3æœˆ26æ—¥ï¼Œæ·±åœ³å¸‚æ–‡åŒ–å¹¿ç”µæ—…æ¸¸ä½“è‚²å±€å‘æ·±åœ³é¾™åå›´æ£‹é˜Ÿå‘å»è´ºä¿¡ï¼Œç¥è´ºå…¶åœ¨2023â€œé›…å±…ä¹æ¸…æ°´æ¹¾æ¯â€ä¸­å›½å›´æ£‹ç”²çº§è”...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o78h5shuv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/03/28/1198908668/a-history-of-hezbollah">A History of Hezbollah</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-28</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-03-28-1198908668-a-history-of-hezbollah/">
    
    
    
    
    
      
    
    Hezbollah is a Lebanese paramilitary organization and political party that&rsquo;s directly supported by the Islamic Republic of Iran. In the wake of the October 7, 2023 Hamas-led attack on Israel, and Israel&rsquo;s invasion of Gaza, Hezbollah and Israel have been exchanging missile fire across the border they share, causing growing fears of a regional conflict with the U.S. and Israel on one side and Iran along with its allies in Hezbollah, Hamas, and the Houthi rebels of Yemen on the other.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about sponsor message choices: <!-- raw HTML omitted -->podcastchoices. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38531863/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">How comparable are patient outcomes in the &#34;real-world&#34; with populations studied in pivotal AML trials?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38531863-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite an increasing desire to use historical cohorts as &ldquo;synthetic&rdquo; controls for new drug evaluation, limited data exist regarding the comparability of real-world outcomes to those in clinical trials. Governmental cancer data often lacks details on treatment, response, and molecular characterization of disease sub-groups. The Australasian Leukaemia and Lymphoma Group National Blood Cancer Registry (ALLG NBCR) includes source information on morphology, cytogenetics, flow cytometry, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38531926/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Cardiac troponin I as predictor for cardiac and other mortality in the German randomized lung cancer screening trial (LUSI)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38531926-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cardiac Troponin I (cTnI) could be used to identify individuals at elevated risk of cardiac death in lung cancer (LC) screening settings. In a population-based, randomized LC screening trial in Germany (&ldquo;LUSI&rdquo; study) serum cTnI was measured by high-sensitivity assay in blood samples collected at baseline, and categorized into unquantifiable/low (&lt; 6 ng/L), intermediate (â‰¥ 6-15 ng/L), and elevated (â‰¥ 16 ng/L). Cox proportional-hazard models were used to estimate risk of all-cause and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532040/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Light Cannabis Use and the Adolescent Brain: An 8-years Longitudinal Assessment of Mental Health, Cognition, and Reward Processing</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532040-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Impairments in reward-related brain activity and cognitive functioning do not appear to precede or succeed cannabis use (i.e., weekly, or monthly use). Cannabis-naÃ¯ve adolescents with conduct problems and more socially engaged with their peers may be at a greater risk for lighter yet persistent cannabis use in the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532323/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240327180710&amp;v=2.18.0.post9&#43;e462414">Neuro-protective Effect of Acetyl-11-keto-Î²-boswellic Acid in a Rat Model of Scopolamine-induced Cholinergic Dysfunction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532323-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240327180710-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The results suggested the effectiveness of AKBA in preventing learning and memory dysfunction induced by scopolamine. Accordingly, these protective effects might be produced by modulating BDNF, cholinergic system function, oxidative stress, and apoptotic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532323/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240328180649&amp;v=2.18.0.post9&#43;e462414">Neuro-protective Effect of Acetyl-11-keto-Î²-boswellic Acid in a Rat Model of Scopolamine-induced Cholinergic Dysfunction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532323-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240328180649-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The results suggested the effectiveness of AKBA in preventing learning and memory dysfunction induced by scopolamine. Accordingly, these protective effects might be produced by modulating BDNF, cholinergic system function, oxidative stress, and apoptotic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532336/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or heart failure as a foundation for establishing rehabilitative, prehabilitative, preventive, and health-promoting measures: rationale, aims, design and methods</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532336-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The PATHFINDER-CHD Registry is poised to offer valuable insights into HF management in ACHD, bridging current knowledge gaps, enhancing patient care, and shaping future research endeavors in this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532495/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532495-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: We performed the first double-stratified GWAS of PCSK9 levels and identified multiple biologically plausible loci with genetic interaction effects. Our results indicate that the observed sexual dimorphism of PCSK9 and its statin-related interactions have a genetic basis. Significant differences in the causal relationship between PCSK9 and LDL-C suggest sex-specific dosages of PCSK9 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532575/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240327180717&amp;v=2.18.0.post9&#43;e462414">Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532575-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240327180717-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of haematological cancers with generally poor clinical outcomes. However, a subset of patients experience durable disease control, and little is known regarding long-term outcomes. The International T-cell Lymphoma Project (ITCLP) is the largest prospectively collected cohort of patients with PTCLs, providing insight into clinical outcomes at academic medical centres globally. We performed a long-term outcome analysis on patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532575/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532575-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of haematological cancers with generally poor clinical outcomes. However, a subset of patients experience durable disease control, and little is known regarding long-term outcomes. The International T-cell Lymphoma Project (ITCLP) is the largest prospectively collected cohort of patients with PTCLs, providing insight into clinical outcomes at academic medical centres globally. We performed a long-term outcome analysis on patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532741/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Post-COVID syndrome and work ability 9-12 months after a SARS-CoV-2 infection among over 9000 employees from the general population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532741-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings revealed risk factors of mWAI &lt;P15 and associations of post-COVID symptom clusters with WAI &lt;P15, which could be potentially prioritized for targeting rehabilitation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38532825/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38532825-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The morphological patterns leading to the diagnosis of glioblastoma may also commonly be observed in several other distinct tumor entities, which can result in a mixed bag of tumors subsumed under this diagnosis. The 2021 WHO Classification of CNS Tumors has separated several of these entities from the diagnosis of glioblastoma, IDH-wildtype. This study determines the DNA methylation classes most likely receiving the diagnosis glioblastoma, IDH wildtype according to the definition by the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533237/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Hot avulsion &lt;em&gt;versus&lt;/em&gt; argon plasma coagulation for the management of the non-ensnarable polyp: A multicenter, randomized controlled trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533237-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Both hot avulsion and argon plasma coagulation are effective and safe modalities to complete resection of non-ensnarable colonic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533342/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Co-occurrence of and factors associated with health risk behaviors among adolescents: a multi-center study in sub-Saharan Africa, China, and India</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533342-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Despite lifelong and detrimental effects, the co-occurrence of health risk behaviors (HRBs) during adolescence remains understudied in low- and middle-income countries. This study examines the co-occurrence of HRBs and its correlates among adolescents in sub-Saharan Africa, China, and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533391/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Personality and the use of cancer screenings - Results of the German National Cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533391-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Particularly higher levels of extraversion, neuroticism and conscientiousness are associated with the use of different cancer screenings. Such knowledge may help to better understand non-participation in cancer screening examinations from a psychological &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38533580/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38533580-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The methyl-lysine reader protein SPIN1 plays important roles in various human diseases. However, targeting methyl-lysine reader proteins has been challenging. Very few cellularly active SPIN1 inhibitors have been developed. We previously reported that our G9a/GLP inhibitor UNC0638 weakly inhibited SPIN1. Here, we present our comprehensive structure-activity relationship study that led to the discovery of compound 11, a dual SPIN1 and G9a/GLP inhibitor, and compound 18 (MS8535), a SPIN1 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534054/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240327180717&amp;v=2.18.0.post9&#43;e462414">Successful Treatment of Refractory Orbital Plasmacytoma with Chimeric Antigen Receptor T Cell Therapy: A Case Report and Review of the Literature</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534054-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240327180717-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Orbital plasmacytoma is a rare plasma cell tumor that may arise as an aggressive form of extramedullary multiple myeloma. Treatment modalities include surgical excision, radiation, and chemotherapy. Chimeric antigen receptor T cell therapy is currently reserved for refractory disease. The authors present a case of a 69-year-old woman with an extensive orbital plasmacytoma refractory to multimodal therapy who was treated with idecabtagene vicleucel chimeric antigen receptor T cell therapy. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534054/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">Successful Treatment of Refractory Orbital Plasmacytoma with Chimeric Antigen Receptor T Cell Therapy: A Case Report and Review of the Literature</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534054-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Orbital plasmacytoma is a rare plasma cell tumor that may arise as an aggressive form of extramedullary multiple myeloma. Treatment modalities include surgical excision, radiation, and chemotherapy. Chimeric antigen receptor T cell therapy is currently reserved for refractory disease. The authors present a case of a 69-year-old woman with an extensive orbital plasmacytoma refractory to multimodal therapy who was treated with idecabtagene vicleucel chimeric antigen receptor T cell therapy. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240327180714&amp;v=2.18.0.post9&#43;e462414">Personalized Driver Gene Prediction Using Graph Convolutional Networks with Conditional Random Fields</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240327180714-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cancer is a complex and evolutionary disease mainly driven by the accumulation of genetic variations in genes. Identifying cancer driver genes is important. However, most related studies have focused on the population level. Cancer is a disease with high heterogeneity. Thus, the discovery of driver genes at the individual level is becoming more valuable but is a great challenge. Although there have been some computational methods proposed to tackle this challenge, few can cover all &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38534453/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240328180651&amp;v=2.18.0.post9&#43;e462414">Personalized Driver Gene Prediction Using Graph Convolutional Networks with Conditional Random Fields</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38534453-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240328180651-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cancer is a complex and evolutionary disease mainly driven by the accumulation of genetic variations in genes. Identifying cancer driver genes is important. However, most related studies have focused on the population level. Cancer is a disease with high heterogeneity. Thus, the discovery of driver genes at the individual level is becoming more valuable but is a great challenge. Although there have been some computational methods proposed to tackle this challenge, few can cover all &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535045/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Photon-Counting Detector CT Virtual Monoenergetic Images in Cervical Trauma Imaging-Optimization of Dental Metal Artifacts and Image Quality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535045-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our research suggests 70 keV might be the best compromise for reducing metal artifacts affecting vascular structures and preventing vascular contrast if solely using VME reconstructions. VME imaging shows only significant effects on the general artifact burden. Vascular structures generally experience fewer metal artifacts than soft tissue due to their greater distance from the teeth, which are a common source of such &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535047/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Optimizing Arterial Vessel Contrast in Portal Venous Phase with Virtual Monoenergetic Images from Photon-Counting Detector CT Scans of the Abdomen-First Clinical Experiences</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535047-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our research suggests that virtual monoenergetic images at 40 keV in Mono+ mode derived from a PCD-CT can be a feasible alternative to a true arterial phase for assessment of vessels with worse CNR and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535070/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Comparison between Ultrasound-Guided and Palpatory Localization of the Dorsal Joint Space of the Shoulder Joint</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535070-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Based on the results, the authors recommend ultrasound imaging of the shoulder joint as well as ultrasound-assisted punctures, especially for inexperienced users. Furthermore, training in ultrasound-assisted interventions should be implemented in future training &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535121/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">New Cases of Maleylacetoacetate Isomerase Deficiency with Detection by Newborn Screening and Natural History over 32 Years: Experience from a German Newborn Screening Center</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535121-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Newborn screening (NBS) for hepatorenal tyrosinemia type I (HT1) based on a determination of succinylacetone is performed in countries worldwide. Recently, biallelic pathogenic variants in GSTZ1 underlying maleylacetoacetate isomerase (MAAI) deficiency have been described as a differential diagnosis in individuals with slightly elevated succinylacetone detected by NBS. We report the experience with NBS for HT1 over 53 months in a large German NBS center and the identification &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535528/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535528-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cutaneous T-cell lymphoma (CTCL) is a devastating, potentially fatal T-lymphocyte malignancy affecting the skin. Despite all efforts, the etiology of this disease remains unknown. Infectious agents have long been suspected as factors or co-factors in CTCL pathogenesis. This review deals with the panel of bacterial and viral pathogens that have been investigated so far in an attempt to establish a potential link between infection/carriage and CTCL development. A special focus is given to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38535773/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Photon Counting Computed Tomography for Accurate Cribriform Plate (Lamina Cribrosa) Imaging in Adult Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38535773-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Detailed visualization of the cribriform plate is challenging due to its intricate structure. This study investigates how computed tomography (CT) with a novel photon counting (PC) detector enhance cribriform plate visualization compared to traditionally used energy-integrated detectors in patients. A total of 40 patients were included in a retrospective analysis, with half of them undergoing PC CT (Naeotom Alpha Siemens Healthineers, Forchheim, Germany) and the other half undergoing CT &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38536110/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240327180738&amp;v=2.18.0.post9&#43;e462414">Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38536110-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240327180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Rationale: Cough is a key symptom in patients with fibrotic interstitial lung disease (ILD). Objective: This study evaluated the prevalence, longitudinal change, associations, and prognostic significance of cough severity in patients with fibrotic ILD. Methods: We included consecutive patients with idiopathic pulmonary fibrosis (IPF) and non-IPF fibrotic ILD who completed the 100mm-Cough Severity Visual Analog Scale (VAS) from the prospective multi-center Canadian Registry for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38537633/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240328180654&amp;v=2.18.0.post9&#43;e462414">A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38537633-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240328180654-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hispanic/Latino children have the highest risk of acute lymphoblastic leukemia (ALL) in the US compared to other racial/ethnic groups, yet the basis of this remains incompletely understood. Through genetic fine-mapping analyses, we identified a new independent childhood ALL risk signal near IKZF1 in self-reported Hispanic/Latino individuals, but not in non-Hispanic White individuals, with an effect size of âˆ¼1.44 (95% confidence interval = 1.33-1.55) and a risk allele frequency of âˆ¼18% &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O6UegaOOl">æ–°å‹å† çŠ¶ç—…æ¯’SARS-CoV-2ç­‰è·¨ç§ä¼ æ’­ä¼ æŸ“ç—…ï¼ˆZoonoticï¼‰æ˜¯æ€ä¹ˆä»è‡ªç„¶ç•Œä¼ æ’­åˆ°äººç±»çš„ï¼Ÿä¸ºä»€ä¹ˆä¼šä¼ æ’­åˆ°äººç±»ï¼Ÿä¸¤å¹´å‰Peter Daszakå’ŒShi Zheng-Liç­‰åˆä½œçš„æ–‡ç« å°±æ¢è®¨äº†...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o6uegaool/">
    
    
    
    
    
      
    
    æ–°å‹å† çŠ¶ç—…æ¯’SARS-CoV-2ç­‰è·¨ç§ä¼ æ’­ä¼ æŸ“ç—…ï¼ˆZoonoticï¼‰æ˜¯æ€ä¹ˆä»è‡ªç„¶ç•Œä¼ æ’­åˆ°äººç±»çš„ï¼Ÿä¸ºä»€ä¹ˆä¼šä¼ æ’­åˆ°äººç±»ï¼Ÿä¸¤å¹´å‰Peter Daszakå’ŒShi Zheng-Liç­‰åˆä½œçš„æ–‡ç« å°±æ¢è®¨äº†åŸå› ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼Œä¸»è¦åŸå› æ˜¯æºå¸¦äººç•œå…±æ‚£ç—…æ¯’åŠ¨ç‰© &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O6VVplGYZ">NIH 2024å¹´é¢„ç®—ä¸ä¼šå‡å°‘ã€‚ç¾å›½ç”Ÿç‰©åŒ»å­¦é¢†åŸŸæœ‰å¤§é‡ä¸­å›½å­¦ç”Ÿå­¦è€…ä¾èµ–NIHç»è´¹ï¼Œæ‰€ä»¥å¯¹ä»–ä»¬è€Œè¨€è¿™æ— ç–‘æ˜¯ä¸ªå–œè®¯ã€‚ä¸Šå‘¨å…­å‡Œæ™¨ï¼ŒBidenç­¾ç½²äº†æœ€ç»ˆçš„2024å¹´é¢„ç®—æ³•æ¡ˆï¼Œè¿™åœº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o6vvplgyz/">
    
    
    
    
    
      
    
    NIH 2024å¹´é¢„ç®—ä¸ä¼šå‡å°‘ã€‚ç¾å›½ç”Ÿç‰©åŒ»å­¦é¢†åŸŸæœ‰å¤§é‡ä¸­å›½å­¦ç”Ÿå­¦è€…ä¾èµ–NIHç»è´¹ï¼Œæ‰€ä»¥å¯¹ä»–ä»¬è€Œè¨€è¿™æ— ç–‘æ˜¯ä¸ªå–œè®¯ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸Šå‘¨å…­å‡Œæ™¨ï¼ŒBidenç­¾ç½²äº†æœ€ç»ˆçš„2024å¹´é¢„ç®—æ³•æ¡ˆï¼Œè¿™åœºé•¿è¾¾6ä¸ªæœˆæ—·æ—¥æŒä¹…çš„é¢„ç®—æ–—äº‰ç»ˆäºå®£å‘Šç»“æŸï¼Œä»¥ä¸¤å…šå¦¥åå‘Šç»ˆã€‚æ¯å¹´10æœˆ1æ—¥æ˜¯ç¾å›½è”é‚¦æ”¿åºœè´¢æ”¿å¹´å¼€å§‹ï¼Œ9æœˆ30æ—¥å‰å›½ä¼šå¿…é¡»é€šè¿‡ä¸‹ä¸€å¹´è´¢æ”¿é¢„ç®—ä»¥é¿å…è”é‚¦æ”¿åºœshutdownã€‚å› ä¸ºå›½ä¼šå‚è®®é™¢ã€ä¼—è®®é™¢åˆ†å±ä¸åŒå…šæ´¾ï¼Œæœ¬åº”è¯¥2023å¹´10æœˆ1æ—¥å‰é€šè¿‡çš„2024å¹´é¢„ç®—æ³•æ¡ˆä¸€ç›´æ²¡æœ‰é€šè¿‡ï¼Œè€Œåªæ˜¯ä»¥stopgapï¼ˆä¸´æ—¶é¢„ç®—ï¼‰çš„å½¢å¼ç»´æŒåˆ°äº†ç°åœ¨ã€‚2023å¹´GOPæ§åˆ¶çš„ä¼—è®®é™¢æ‰¬è¨€è¦å‰Šå‡NIH 5.8%é¢„ç®—ï¼Œè¿™å°†è¿‘28äº¿ç¾å…ƒï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70IF2dq1">ğŸ”»è‰¾å¸ƒæ‹‰å§†æ–¯ã€‚ğŸ”»æºï¼šĞšĞ¸Ñ€Ğ¸Ğ»Ğ» Ğ¤Ñ‘Ğ´Ğ¾Ñ€Ğ¾Ğ² [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70if2dq1/">
    
    
    
    
    
      
    
    ğŸ”»è‰¾å¸ƒæ‹‰å§†æ–¯ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šĞšĞ¸Ñ€Ğ¸Ğ»Ğ» Ğ¤Ñ‘Ğ´Ğ¾Ñ€Ğ¾Ğ² <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70QltLgv">ğŸ”»æ³¨å†Œå·ä¸º A6-EDM çš„é˜¿è”é…‹èˆªç©ºå…¬å¸ A380 é£æœºåœ¨è«æ–¯ç§‘å¤šè«æ°å¤šæ²ƒæœºåœºå‘ç”Ÿåœ°é¢äº‹ æ•…ã€‚ğŸ”»ç›®å‰çš„æ¶ˆæ¯æ˜¯59å²çš„åœ°é¢è½¦å¸æœºåœ¨é©¾é©¶ä¸­çªç„¶ä¸­é£äº†ï¼Œå¤±å»äº†å¯¹è½¦è¾†çš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70qltlgv/">
    
    
    
    
    
      
    
    ğŸ”»æ³¨å†Œå·ä¸º A6-EDM çš„é˜¿è”é…‹èˆªç©ºå…¬å¸ A380 é£æœºåœ¨è«æ–¯ç§‘å¤šè«æ°å¤šæ²ƒæœºåœºå‘ç”Ÿåœ°é¢äº‹ æ•…ã€‚<!-- raw HTML omitted -->ğŸ”»ç›®å‰çš„æ¶ˆæ¯æ˜¯59å²çš„åœ°é¢è½¦å¸æœºåœ¨é©¾é©¶ä¸­çªç„¶ä¸­é£äº†ï¼Œå¤±å»äº†å¯¹è½¦è¾†çš„æ§åˆ¶ï¼Œç›®å‰æ­£åœ¨åŒ»é™¢ã€‚<!-- raw HTML omitted -->ğŸ”»å•Šè¿™â€¦â€¦<!-- raw HTML omitted -->ğŸ”»ç”±äºåœ¨ä¿„ç½—æ–¯ç»´ä¿®æ­¤ç±»é£æœºçš„èƒ½åŠ›ä¸‹é™ï¼Œå—æŸçš„ A380 ç»™è¿è¥å•†å¸¦æ¥äº†æŒ‘æˆ˜ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šFlightradar24ã€ĞÑŒÑÑĞ°Ñ‡/Ğ”Ğ²Ğ°Ñ‡<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70TFrfQV">åœ¨æŠ˜å å’Œå¹³æ¿çš„é€‰æ‹©ä¸­çº ç»“çš„åŸå› ï¼Œä¸»è¦æ˜¯å‡ºé—¨çš„ä¾¿æºæ€§ï¼šå¦‚æœæŠ˜å èƒ½æ»¡è¶³éœ€æ±‚ï¼Œå°±å¯ä»¥å°‘å¸¦ä¸ªå¤§åŒ…ï¼Œä¸ç„¶å°±ç®—æ˜¯èƒŒipad miniå‡ºé—¨ä¹Ÿå¾—å¸¦å¤§åŒ…ï¼Œè¿˜ä¸å¦‚ç›´æ¥ä¸Š11-12å¯¸çš„å¹³...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70tfrfqv/">
    
    
    
    
    
      
    
    åœ¨æŠ˜å å’Œå¹³æ¿çš„é€‰æ‹©ä¸­çº ç»“çš„åŸå› ï¼Œä¸»è¦æ˜¯å‡ºé—¨çš„ä¾¿æºæ€§ï¼šå¦‚æœæŠ˜å èƒ½æ»¡è¶³éœ€æ±‚ï¼Œå°±å¯ä»¥å°‘å¸¦ä¸ªå¤§åŒ…ï¼Œä¸ç„¶å°±ç®—æ˜¯èƒŒipad miniå‡ºé—¨ä¹Ÿå¾—å¸¦å¤§åŒ…ï¼Œè¿˜ä¸å¦‚ç›´æ¥ä¸Š11-12å¯¸çš„å¹³æ¿â€¦â€¦<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»é—®ä¸€ä¸ªé—®é¢˜ï¼Œvivo è¿™ç§å®‰å“æŠ˜å å±ï¼Œåœ¨å®é™…ä½¿ç”¨ä¸­èƒ½æ›¿ä»£ ipad ç”¨æ¥è¯»è®ºæ–‡å’Œå¼€å¤šçª—å£å‘å¾®åšä¹ˆï¼Ÿ<!-- raw HTML omitted -->ğŸ”»æƒ³ä¹°ä¸€ä¸ªè¯•è¯•çœ‹ï¼Œä½†æ˜¯å¯¹æŠ˜ç—•æœ‰ç‚¹è†ˆåº”ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O70YEeHsu">æˆ‘æœ‰å¾ˆå¤šç¬”è®°æœ¬äº†ï¼Œæˆ‘ç°åœ¨æ˜¯éœ€è¦åœ¨æ‰‹æœºå’Œç¬”è®°æœ¬ä¹‹é—´å†è¡¥å……ä¸€ä¸ªæ›´è½»ä¸€ç‚¹çš„ã€‚//@sj2wk:ä¸ºä»€ä¹ˆä½ æ²¡æœ‰è€ƒè™‘å¾®è½¯çš„surfaceå‘¢ï¼Ÿï¼Ÿ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»é—®...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o70yeehsu/">
    
    
    
    
    
      
    
    æˆ‘æœ‰å¾ˆå¤šç¬”è®°æœ¬äº†ï¼Œæˆ‘ç°åœ¨æ˜¯éœ€è¦åœ¨æ‰‹æœºå’Œç¬”è®°æœ¬ä¹‹é—´å†è¡¥å……ä¸€ä¸ªæ›´è½»ä¸€ç‚¹çš„ã€‚//<!-- raw HTML omitted -->@sj2wk<!-- raw HTML omitted -->:ä¸ºä»€ä¹ˆä½ æ²¡æœ‰è€ƒè™‘å¾®è½¯çš„surfaceå‘¢ï¼Ÿï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»é—®ä¸€ä¸ªé—®é¢˜ï¼Œvivo è¿™ç§å®‰å“æŠ˜å å±ï¼Œåœ¨å®é™…ä½¿ç”¨ä¸­èƒ½æ›¿ä»£ ipad ç”¨æ¥è¯»è®ºæ–‡å’Œå¼€å¤šçª—å£å‘å¾®åšä¹ˆï¼Ÿ<!-- raw HTML omitted -->ğŸ”»æƒ³ä¹°ä¸€ä¸ªè¯•è¯•çœ‹ï¼Œä½†æ˜¯å¯¹æŠ˜ç—•æœ‰ç‚¹è†ˆåº”ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O710GmVGX">ğŸ”»ä»¥è‰²åˆ—æ²¡æ‹›äº†ã€‚ğŸ”»æºï¼šåŠå²›ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o710gmvgx/">
    
    
    
    
    
      
    
    ğŸ”»ä»¥è‰²åˆ—æ²¡æ‹›äº†ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šåŠå²›ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71fQDg30">ğŸ”»çœ‹äº†å‡ é›†ï¼Œè¿™ä½è€å¸ˆçš„ç¤¾ä¼šç§‘å­¦æ¦‚è®ºç¡®å®è®²çš„ä¸é”™ã€‚ğŸ”»æ¦‚è®ºç±»ï¼Œæœ‰æç‚¼ã€æœ‰æƒ³æ³•ã€æœ‰ç ”ç©¶ï¼Œè€Œä¸”å¾ˆä¼šè®²è¯¾ï¼Œä¸æ˜¯ç®€å•çš„å¿µPPTï¼Œä¸Šè¯¾å†…å®¹æœ‰çµé­‚ã€‚ğŸ”»çœ‹äº†ä¸‹CåˆŠè®ºæ–‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71fqdg30/">
    
    
    
    
    
      
    
    ğŸ”»çœ‹äº†å‡ é›†ï¼Œè¿™ä½è€å¸ˆçš„ç¤¾ä¼šç§‘å­¦æ¦‚è®ºç¡®å®è®²çš„ä¸é”™ã€‚<!-- raw HTML omitted -->ğŸ”»æ¦‚è®ºç±»ï¼Œæœ‰æç‚¼ã€æœ‰æƒ³æ³•ã€æœ‰ç ”ç©¶ï¼Œè€Œä¸”å¾ˆä¼šè®²è¯¾ï¼Œä¸æ˜¯ç®€å•çš„å¿µPPTï¼Œä¸Šè¯¾å†…å®¹æœ‰çµé­‚ã€‚<!-- raw HTML omitted -->ğŸ”»çœ‹äº†ä¸‹CåˆŠè®ºæ–‡ï¼Œè¿™ä½è€å¸ˆä¸»è¦æ˜¯åšä¿¡æ¯èµ„æºç®¡ç†æ–¹å‘ç ”ç©¶çš„ã€‚å…¶å®ä¿¡æ¯å­¦ã€å›¾ä¹¦é¦†å­¦å°±æ˜¯â€œæƒ… æŠ¥ å­¦â€ï¼Œæˆ‘ä»¬ç†Ÿæ‚‰çš„â€œæœç´¢å¼•æ“â€ã€â€œæ€ç»´å¯¼å›¾â€ã€â€œå¼€æºæƒ…æŠ¥åˆ†æâ€ç­‰ç­‰æ¦‚å¿µï¼Œä¸è¿™äº›åŸºç¡€å­¦ç§‘æŠ€èƒ½åˆ†ä¸å¼€ã€‚<!-- raw HTML omitted -->ğŸ”»é«˜æ ¡é‡Œç¤¾ç§‘ç±»æœ‰å¾ˆå¤šè¿™æ ·é»˜é»˜åšå­¦é—®çš„è€å¸ˆï¼Œä»–ä»¬å¹³æ—¶ä¹Ÿä¸ç©è‡ªåª’ä½“ã€‚<!-- raw HTML omitted -->ğŸ”»ç„¶è€Œå¤§å®¶å¯¹é«˜æ ¡ç¤¾ç§‘ç±»çš„åå°è±¡å¾€å¾€éƒ½æ¥è‡ªä¸€äº›å¥½å‡ºåä½†æ˜¯ä¸å¥½åšå­¦é—®çš„é«˜æ ¡äººã€‚<!-- raw HTML omitted -->ğŸ”»åœ°å€æ˜¯ï¼š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;/sp &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71iREVrX">çœ‹ï¼Œæ ¹æœ¬æ²¡æœ‰äººå…³å¿ƒæ³¢å…°ã€‚æ™šå®‰ã€‚//@ä¹–å“ˆ33:æ‰€ä»¥æ˜¯åšç¾è¿˜æ˜¯è¨æ‘©è€¶ï¼Ÿ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»åœ¨è®¿é—®éƒ¨é˜Ÿæ—¶ï¼Œå¢å¡ç”³ç§‘ä¸ä¸€åæŒ‡æŒ¥å®˜äº¤è°ˆï¼Œå‘ä»–è¯¢é—®äº†å¯¹æŠ—...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71irevrx/">
    
    
    
    
    
      
    
    çœ‹ï¼Œæ ¹æœ¬æ²¡æœ‰äººå…³å¿ƒæ³¢å…°ã€‚æ™šå®‰ã€‚//<!-- raw HTML omitted -->@ä¹–å“ˆ33<!-- raw HTML omitted -->:æ‰€ä»¥æ˜¯åšç¾è¿˜æ˜¯è¨æ‘©è€¶ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»åœ¨è®¿é—®éƒ¨é˜Ÿæ—¶ï¼Œå¢å¡ç”³ç§‘ä¸ä¸€åæŒ‡æŒ¥å®˜äº¤è°ˆï¼Œå‘ä»–è¯¢é—®äº†å¯¹æŠ—æ³¢ç½—çš„æµ·å›½å®¶å’Œå¤ºå–æ³¢å…°éƒ¨åˆ†é¢†åœŸä»¥ä¾¿å°†ç™½ä¿„ç½—æ–¯ä¸åŠ é‡Œå®æ ¼å‹’è¿æ¥èµ·æ¥çš„æˆ˜ç•¥ã€‚<!-- raw HTML omitted -->ğŸ”»ä½†æ˜¯å¾ˆå¤šäººåªå…³æ³¨äº†å¢å¡ç”³ç§‘åœ¨ rua ä¸€æ¡ç‹—ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šç™½é€šç¤¾ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;sp &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71lcuGrp">ğŸ”»6ğŸ”»æºï¼šåŠå²› [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71lcugrp/">
    
    
    
    
    
      
    
    ğŸ”»6<!-- raw HTML omitted -->ğŸ”»æºï¼šåŠå²› <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71vljcaf">ğŸ”»å•Šï¼Ÿï¼Ÿï¼ŸğŸ”»[è´¹è§£]ğŸ”»æ˜¯çš„ï¼Œæˆ‘çŸ¥é“è¿™æ˜¯é»‘è¢çº å¯Ÿé˜Ÿçš„è¡ç”Ÿå‰§â€¦â€¦ğŸ”»ä½†æ˜¯ï¼Œæ€ä¹ˆæˆè¿™ä¸ªæ ·å­äº†â€¦â€¦ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71vljcaf/">
    
    
    
    
    
      
    
    ğŸ”»å•Šï¼Ÿï¼Ÿï¼Ÿ<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ”»æ˜¯çš„ï¼Œæˆ‘çŸ¥é“è¿™æ˜¯é»‘è¢çº å¯Ÿé˜Ÿçš„è¡ç”Ÿå‰§â€¦â€¦<!-- raw HTML omitted -->ğŸ”»ä½†æ˜¯ï¼Œæ€ä¹ˆæˆè¿™ä¸ªæ ·å­äº†â€¦â€¦ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O71yw9lt6">ï¼Ÿ è¯„è®ºé…å›¾ - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»å•Šï¼Ÿï¼Ÿï¼ŸğŸ”»[è´¹è§£]ğŸ”»æ˜¯çš„ï¼Œæˆ‘çŸ¥é“è¿™æ˜¯é»‘è¢çº å¯Ÿé˜Ÿçš„è¡ç”Ÿå‰§â€¦â€¦ğŸ”»ä½†æ˜¯ï¼Œæ€ä¹ˆæˆè¿™ä¸ªæ ·å­äº†â€¦â€¦ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o71yw9lt6/">
    
    
    
    
    
      
    
    ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¯„è®ºé…å›¾<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»å•Šï¼Ÿï¼Ÿï¼Ÿ<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted -->&lt;img alt=&quot;[è´¹è§£]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_feijie-c1df37ef03.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_feijie-c1df37ef03.png&quot;</a> style=&ldquo;width:1em; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O6UkxC8qx">å¾®åšå¾ˆè’è¯çš„æµé‡æœºåˆ¶ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o6ukxc8qx/">
    
    
    
    
    
      
    
    å¾®åšå¾ˆè’è¯çš„æµé‡æœºåˆ¶ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O6XNBpe1t">å¿ƒæƒ…å¤æ‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o6xnbpe1t/">
    
    
    
    
    
      
    
    å¿ƒæƒ…å¤æ‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O708l5vW6">çƒŸé¬¼ä»¬çœŸå‚»é€¼å•Š[å“†å•¦Aæ¢¦å®³æ€•] [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o708l5vw6/">
    
    
    
    
    
      
    
    çƒŸé¬¼ä»¬çœŸå‚»é€¼å•Š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O7034ft4n">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.nogi46ann&amp;nogizaka46 X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o7034ft4n/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogi46ann&amp;nogizaka46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1ho5z4cncouj31530u">https://tvax1.sinaimg.cn/large/006z6nxLgy1ho5z4cncouj31530u</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O70e8wa0U">å•Šï¼Ÿ//@æƒ³æ—çš„è¡°è¡°TvT:[å“†å•¦Aæ¢¦åƒæƒŠ]//@è¥¿é‡æ…§:[å‚»çœ¼]//@CXBLD:[å“†å•¦Aæ¢¦å®³æ€•] - è½¬å‘ @ç«¹æ— å¿ƒjk:&amp;ensp;æ¡¥æœ¬å¥ˆå¥ˆæœªçœ‹ğŸ‘€å›¾ç‰‡æœ‰æƒŠå–œå¨œå¨œæ•[å“ˆå“ˆ][å“ˆå“ˆ][å“ˆå“ˆ]å›¾æ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o70e8wa0u/">
    
    
    
    
    
      
    
    å•Šï¼Ÿ//<!-- raw HTML omitted -->@æƒ³æ—çš„è¡°è¡°TvT<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@è¥¿é‡æ…§<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@CXBLD&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O718jag2I">å¥½å–œæ¬¢æ‰“æ¸¸æˆå•ŠğŸ¥¹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o718jag2i/">
    
    
    
    
    
      
    
    å¥½å–œæ¬¢æ‰“æ¸¸æˆå•ŠğŸ¥¹  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719JoDfl">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.03.27 12:48ã€Œå´­æ–°çš„ã€ä½ å¥½ä»Šå¤©ä¸ç”¨æ‰“å¼€çª—å¸˜ä¹Ÿèƒ½çŸ¥é“æ˜¯æ™´å¤©ï¼Œå¾ˆå¼€å¿ƒä¸è¿‡ï¼Œä¸ç®¡æ˜¯é›¨å¤©è¿˜æ˜¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719jodfl/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%25">https://m.weibo.cn/search?containerid=231522type%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719Lm6Mm">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.03.27 15:44ã€ŒéŸ³ä¹ã€ä»Šå¤©çš„æ™šé¤ä½ è¦åƒä»€ä¹ˆï¼Ÿâ˜ºï¸æˆ‘è¦åƒä»€ä¹ˆå¥½å‘¢ã€‚ä½ å–œæ¬¢çš„è”¬èœæ˜¯ä»€ä¹ˆã€‚ä»Š...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719lm6mm/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D1">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D1</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719OyP3o">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.03.27 19:43ã€Œæ¬¸å˜¿å˜¿ã€æœ€è¿‘ï¼Œåªæ˜¯ç¨å¾®åŠªåŠ›ä¸€ç‚¹å°±ä¼šæ„Ÿåˆ°ç–²å€¦ï¼Œè§‰å¾—å›°ã€‚ã€‚å¾—é€æ¸é‡æ–°æå‡ä½“...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719oyp3o/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26">https://m.weibo.cn/search?containerid=231522type%3D1%26</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O719VnNb7">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .#ä¹…ä¿çš„æ’ç»ƒæœ##YABAIYO##YABAIYO##å‡ºå·å“²æœ—# æ¡‘#ä»Šæ™šæ˜¯è¿™ä¸ªå¹´åº¦æœ€åçš„##å¼€å¹•å‰æœ€åçš„##ä¹ƒæœ¨å‚46ANN...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o719vnnb7/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O71a2ayOD">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å22:00ï½ï¼ˆJSTï¼‰å¯Œå£«ç”µè§†ç½‘ã€é€±åˆŠãƒŠã‚¤ãƒŠã‚¤ãƒŸãƒ¥ãƒ¼ã‚¸ãƒƒã‚¯ã€è¯·ä¸€å®šè¦è§‚çœ‹ğŸ•ºğŸ»éå¸¸å¼€å¿ƒèƒ½ä¹…è¿åœ°è·Ÿ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o71a2ayod/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O71feyp0o">æ„Ÿè§‰å¤é£æ­Œæˆ‘åˆçˆ±å¬äº†ğŸ¥¹ğŸ«°ğŸ»</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o71feyp0o/">
    
    
    
    
    
      
    
    æ„Ÿè§‰å¤é£æ­Œæˆ‘åˆçˆ±å¬äº†ğŸ¥¹ğŸ«°ğŸ»  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O71uPmayW">å”‰ï¼ŒçœŸçš„å–œæ¬¢ç»ªå„¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o71upmayw/">
    
    
    
    
    
      
    
    å”‰ï¼ŒçœŸçš„å–œæ¬¢ç»ªå„¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6UKSmJNT">è½‰ç™¼å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# æœ€è¿‘ï¼Œæˆ‘ç»å¸¸è·Ÿå¤§æ¦‚æ˜¯å»äº†å¤§å­¦æ¯•ä¸šå…¸ç¤¼çš„äººæ“¦èº«è€Œè¿‡ã€‚æ­å–œæ¯•ä¸šã€‚å¦‚æœæˆ‘ä¹Ÿæ˜¯å¤§å­¦ç”Ÿçš„è¯ï¼Œä¹Ÿæ˜¯è¦æ¯•ä¸šçš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6uksmjnt/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6UKtF4pc">è½‰ç™¼å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.03.26 22:38ã€Œå‘œå‘¼å‘¼ã€è¯´èµ·æ¥æˆ‘æ²¡åœ¨ä»»ä½•åœ°æ–¹å‘å°é¢ç…§çš„èŠ±çµ®ç…§å‘¢ã€‚æ¯”å¹³å¸¸æ›´æœ‰æƒ…è°ƒçš„å·å‘æ–¹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6uktf4pc/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6ZLw5sV2">çœŸå¥½çœ‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6zlw5sv2/">
    
    
    
    
    
      
    
    çœŸå¥½çœ‹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O6Zni6hVp">åˆ†äº«å›¾ç‰‡ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o6zni6hvp/">
    
    
    
    
    
      
    
    åˆ†äº«å›¾ç‰‡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O70bH0tOB">å®®åŸ26è™Ÿé‚„åœ¨ä¸‹é›ª [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o70bh0tob/">
    
    
    
    
    
      
    
    å®®åŸ26è™Ÿé‚„åœ¨ä¸‹é›ª <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6WEgDAf8">ç¬¬24å±Šé˜¿å«æ¡å±±æ¯ä¸­æ—¥å¯¹æŠ—èµ›ï¼Œæœ€ç»ˆæ¨é¼æ–°ä¸­ç›˜æˆ˜èƒœä¸€åŠ›è¾½è·å¾—ä¼˜èƒœã€‚ä»¥ä¸‹æ˜¯åŒæ–¹èµ›åæ„Ÿæƒ³ï¼šæ¨é¼æ–°ï¼šã€å›é¡¾ä»Šå¤©è¿™ç›˜æ£‹ï¼Œç„¶åä»€ä¹ˆæ—¶å€™æ„è¯†åˆ°èµ¢æ£‹äº†ã€‘ä¸€å¼€å§‹ç™½æ£‹åœ¨ä¸Šé¢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6wegdaf8/">
    
    
    
    
    
      
    
    ç¬¬24å±Šé˜¿å«æ¡å±±æ¯ä¸­æ—¥å¯¹æŠ—èµ›ï¼Œæœ€ç»ˆæ¨é¼æ–°ä¸­ç›˜æˆ˜èƒœä¸€åŠ›è¾½è·å¾—ä¼˜èƒœã€‚ä»¥ä¸‹æ˜¯åŒæ–¹èµ›åæ„Ÿæƒ³ï¼š<!-- raw HTML omitted --><!-- raw HTML omitted -->æ¨é¼æ–°ï¼š<!-- raw HTML omitted -->ã€å›é¡¾ä»Šå¤©è¿™ç›˜æ£‹ï¼Œç„¶åä»€ä¹ˆæ—¶å€™æ„è¯†åˆ°èµ¢æ£‹äº†ã€‘ä¸€å¼€å§‹ç™½æ£‹åœ¨ä¸Šé¢è·³äº†æŒ¡ä¸‹å»ç„¶åé è¿‡æ¥ï¼Œé‚£ä¸ªæ—¶å€™é»‘æ£‹è¿˜å¾ˆåšï¼Œç™½æ£‹æŒºè–„ï¼Œé‚£ä¸ªæ—¶å€™æ„Ÿè§‰è¿˜å¯ä»¥ã€‚å·¦è¾¹é»‘æ£‹å¤§é£çš„æ—¶å€™æ„Ÿè§‰å·¦è¾¹ä¸å¤ªå¥½åšæ´»ï¼Œè¿™ä¸ªæ—¶å€™æ„Ÿè§‰ç™½æ£‹è¿˜å¯ä»¥ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ã€ä¼˜èƒœä¹‹åæ„Ÿå—å¦‚ä½•ã€‘é¦–å…ˆéå¸¸æ„Ÿè°¢é˜¿å«å®—è¿™ä¹ˆå¤šå¹´çš„æ”¯æŒå’ŒåŠªåŠ›ï¼Œå¾—ä»¥ç»§ç»­ä¸¾åŠã€‚ç„¶åä¸­æ—¥å¯¹æŠ—çš„ä¼ ç»Ÿä¹Ÿä¿ç•™ä¸‹æ¥ï¼Œèº«ä¸ºæ£‹æ‰‹éå¸¸æ„Ÿæ¿€ã€‚é˜¿å«å®—çš„å¯¹å±€ç¯å¢ƒéå¸¸å¥½ï¼Œæˆ‘åœ¨ä¸­å›½å’Œä¸–ç•Œå¤§èµ›ä¸­æ²¡æœ‰è¿‡è¿™ä¹ˆå¥½çš„ç¯å¢ƒå¯¹å±€ï¼Œå¯¹æ­¤éå¸¸æ„Ÿè°¢ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸€åŠ›è¾½ï¼š<!-- raw HTML omitted -->ã€å›é¡¾ä¸€ä¸‹ä»Šå¤©è¿™ç›˜æ£‹ã€‘å¸ƒå±€é˜¶æ®µæ¯ä¸€æ‰‹æ£‹éƒ½æ¯”è¾ƒå¤æ‚ï¼Œå®æˆ˜è¢«é»‘æ£‹è¿ç‰‡ä¹‹åæ„Ÿè§‰ä¸å¤ªå¥½ä¸‹ï¼Œæˆ–è®¸ä¹‹å‰æœ‰æ›´å¥½çš„ä¸‹æ³•ã€‚å·¦è¾¹çš„å±€é¢çœ¼è§çš„éå¸¸éš¾ä¸‹ï¼Œåªèƒ½é€‰æ‹©æ²»å­¤ã€‚å®æˆ˜æ²»å­¤çš„éš¾åº¦ä¹Ÿéå¸¸å¤§ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ã€è¿™æ˜¯ä½ ç¬¬2æ¬¡å‚åŠ ä¸­æ—¥å¯¹æŠ—ï¼Œå¯¹ä¸‹ä¸€å±Šæ¯”èµ›ï¼Œä»¥åŠå¯¹ä»Šåçš„ä¸–ç•Œå¤§èµ›æœ‰ä»€ä¹ˆæƒ³æ³•ã€‘è¿™ä¸€æ¬¡å’Œ5å¹´å‰çš„ç»“æœéƒ½å¾ˆé—æ†¾ï¼Œæ£‹å±€çš„å†…å®¹ä¹Ÿå¾ˆç³Ÿç³•ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6WghBZWQ">æ¨é¼æ–°ï¼šå¥½åƒç›˜è…¿åä¹Ÿä¸æ˜¯ä¸è¡Œ#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6wghbzwq/">
    
    
    
    
    
      
    
    æ¨é¼æ–°ï¼šå¥½åƒç›˜è…¿åä¹Ÿä¸æ˜¯ä¸è¡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6WKErgRa">ä¸ç›¸ä¿¡åªæœ‰æˆ‘ç¬¬ä¸€æ„Ÿä¼šè§‰å¾—ï¼Œä¸­é—´Cä½çš„ç¥ç§˜å˜‰å®¾æ˜¯ç”³çœŸè°#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6wkergra/">
    
    
    
    
    
      
    
    ä¸ç›¸ä¿¡åªæœ‰æˆ‘ç¬¬ä¸€æ„Ÿä¼šè§‰å¾—ï¼Œä¸­é—´Cä½çš„ç¥ç§˜å˜‰å®¾æ˜¯ç”³çœŸè°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O6XTc4k1C">â€» åŒä¸€äººç‰©#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o6xtc4k1c/">
    
    
    
    
    
      
    
    â€» åŒä¸€äººç‰©<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/00">https://tvax1.sinaimg.cn/large/00</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O7007kQUE">é˜¿å«æ¡å±±æ¯ä¸­æ—¥å¯¹æŠ—ï¼Œçœ‹å®Œäº†è¿™ä¸¤å¤©çš„æŠ¥é“ï¼Œä¸€åŠ›è¾½é™¤äº†äººåœ¨æ—¥æœ¬ï¼Œæ€»æ„Ÿè§‰åƒæ˜¯åœ¨å®¢åœºä½œæˆ˜ï¼Œåå€’æ˜¯æ¨é¼æ–°æ¸¸åˆƒæœ‰ä½™ã€‚æ— è®ºæ˜¯æŠ¥é“å›¢é˜Ÿï¼Œè¿˜æ˜¯èµ›åå¤ç›˜ï¼Œéƒ½æ˜¯æˆ‘ä»¬ä¸­æ–¹æ›´åŠ ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o7007kque/">
    
    
    
    
    
      
    
    é˜¿å«æ¡å±±æ¯ä¸­æ—¥å¯¹æŠ—ï¼Œçœ‹å®Œäº†è¿™ä¸¤å¤©çš„æŠ¥é“ï¼Œä¸€åŠ›è¾½é™¤äº†äººåœ¨æ—¥æœ¬ï¼Œæ€»æ„Ÿè§‰åƒæ˜¯åœ¨å®¢åœºä½œæˆ˜ï¼Œåå€’æ˜¯æ¨é¼æ–°æ¸¸åˆƒæœ‰ä½™ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æ— è®ºæ˜¯æŠ¥é“å›¢é˜Ÿï¼Œè¿˜æ˜¯èµ›åå¤ç›˜ï¼Œéƒ½æ˜¯æˆ‘ä»¬ä¸­æ–¹æ›´åŠ ç§¯æã€‚æ—¥æœ¬æ–¹é¢é™¤äº†é˜¿å«å®—é¼åŠ›æ”¯æŒèµ›äº‹ä¹‹å¤–ï¼Œæˆ‘è§‰å¾—æ—¥æœ¬åª’ä½“éƒ½æ²¡æœ‰æˆ‘ä»¬ç”¨å¿ƒã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æ‰€ä»¥æ—¥æœ¬å›´æ£‹æˆç»©ä¸å¥½åªæ˜¯ä¸€ä¸ªå¾ˆæ®‹é…·çš„ç»“æœï¼Œåœ¨è¿™ä¸ªç»“æœèƒŒåå…¶å®æœ‰å¾ˆå¤šå¾ˆå¤šæ‹‰èƒ¯çš„åœ°æ–¹ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O701NaDjJ">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ¨é¼æ–°å…¨åœºå‹åˆ¶ä¸€åŠ›è¾½ï¼Œå± é¾™å®Œèƒœã€‹ #å›´æ£‹# å›´æ£‹ æ¨é¼æ–°å…¨åœºå‹åˆ¶ä¸€åŠ›è¾½ï¼Œå± é¾™å®Œèƒœ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o701nadjj/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ¨é¼æ–°å…¨åœºå‹åˆ¶ä¸€åŠ›è¾½ï¼Œå± é¾™å®Œèƒœã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O6ZczxvPg">ä¹…ä¿å²ç»ªé‡Œ - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ 240327ã€Œé€±åˆŠãƒŠã‚¤ãƒŠã‚¤ãƒŸãƒ¥ãƒ¼ã‚¸ãƒƒã‚¯ã€ãƒãƒ£ãƒ³ã‚¹ã¯å¹³ç­‰ å±±ä¸‹ç¾æœˆæ•™ä¼šçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o6zczxvpg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%9C%88&amp;amp;containerid=10080893">https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E%E6%9C%88&amp;amp;containerid=10080893</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O6ZeYkqF0">ä¹…ä¿å²ç»ªé‡Œvia.é€±åˆŠãƒŠã‚¤ãƒŠã‚¤ãƒŸãƒ¥ãƒ¼ã‚¸ãƒƒã‚¯ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o6zeykqf0/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.é€±åˆŠãƒŠã‚¤ãƒŠã‚¤ãƒŸãƒ¥ãƒ¼ã‚¸ãƒƒã‚¯ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLg">https://tvax3.sinaimg.cn/large/006z6nxLg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O6ZZ0m6DL">ä¹…ä¿å²ç»ªé‡Œvia.nogi46ann&amp;nogizaka46 X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o6zz0m6dl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.nogi46ann&amp;nogizaka46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006">https://tvax2.sinaimg.cn/large/006</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70FczSaE">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.03.27 12:48ã€Œå´­æ–°çš„ã€ä½ å¥½ä»Šå¤©ä¸ç”¨æ‰“å¼€çª—å¸˜ä¹Ÿèƒ½çŸ¥é“æ˜¯æ™´å¤©ï¼Œå¾ˆå¼€å¿ƒä¸è¿‡ï¼Œä¸ç®¡æ˜¯é›¨å¤©è¿˜æ˜¯æ™´å¤©ï¼Œæœ€è¿‘æˆ‘èµ·åºŠéƒ½æœ‰äº›è´¹åŠ›ã€‚è¦æ‰¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70fczsae/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70FlsUX1">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.03.27 15:44ã€ŒéŸ³ä¹ã€ä»Šå¤©çš„æ™šé¤ä½ è¦åƒä»€ä¹ˆï¼Ÿâ˜ºï¸æˆ‘è¦åƒä»€ä¹ˆå¥½å‘¢ã€‚ä½ å–œæ¬¢çš„è”¬èœæ˜¯ä»€ä¹ˆã€‚ä»Šå¤©æ—©ä¸Šå‘¢ï¼Œçªç„¶æ€å¿µèµ·å¤å¤©éœ‡æƒŠäº†å‘¢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70flsux1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isn">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70FsqGDy">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.03.27 19:43ã€Œæ¬¸å˜¿å˜¿ã€æœ€è¿‘ï¼Œåªæ˜¯ç¨å¾®åŠªåŠ›ä¸€ç‚¹å°±ä¼šæ„Ÿåˆ°ç–²å€¦ï¼Œè§‰å¾—å›°ã€‚ã€‚å¾—é€æ¸é‡æ–°æå‡ä½“åŠ›æ‰è¡Œã€‚å‘¼ï½ï¼Œä¸€è¾¹è¿™ä¹ˆè¯´ï¼Œæˆ‘ä¹Ÿæ‰“...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70fsqgdy/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;a">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;a</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70LMxIqv">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .#ä¹…ä¿çš„æ’ç»ƒæœ##YABAIYO##YABAIYO##å‡ºå·å“²æœ—# æ¡‘#ä»Šæ™šæ˜¯è¿™ä¸ªå¹´åº¦æœ€åçš„##å¼€å¹•å‰æœ€åçš„##ä¹ƒæœ¨å‚46ANN##è¦å¬å“¦#â€»YABAIYO YABAIYOï¼ˆç³Ÿäº†...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70lmxiqv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->.<!-- raw HTML omitted -->&lt;a  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O70MajVYs">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å22:00ï½ï¼ˆJSTï¼‰å¯Œå£«ç”µè§†ç½‘ã€é€±åˆŠãƒŠã‚¤ãƒŠã‚¤ãƒŸãƒ¥ãƒ¼ã‚¸ãƒƒã‚¯ã€è¯·ä¸€å®šè¦è§‚çœ‹ğŸ•ºğŸ»éå¸¸å¼€å¿ƒèƒ½ä¹…è¿åœ°è·ŸãƒŠã‚¤ãƒŠã‚¤æ¡‘å’Œæ£®ç”°æ¡‘è§é¢â€¦ğŸŒ±half ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o70majvys/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U1qp6Tl">æŸ¯æ´#å†œå¿ƒæ¯##èµ›äº‹æŠ¥é“# è§†é¢‘æ¥æº:å¤®5 ä½“è‚²ä¸–ç•Œç½‘é¡µé“¾æ¥ æŸ¯æ´ä¹æ®µæ–°é—»æ¬è¿å·çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u1qp6tl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å†œå¿ƒæ¯#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=2">https://m.weibo.cn/search?containerid=2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U28j61X">æŸ¯æ´#è¥¿å—æ£‹ç‹èµ›##èµ›äº‹æŠ¥é“# è§†é¢‘æ¥æº:å¤®5 ä½“è‚²æ–°é—»ç½‘é¡µé“¾æ¥ æŸ¯æ´ä¹æ®µæ–°é—»æ¬è¿å·çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u28j61x/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#è¥¿å—æ£‹ç‹èµ›#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?container">https://m.weibo.cn/search?container</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U2DrieA">æŸ¯æ´#è¥¿å—æ£‹ç‹èµ›# #èµ›äº‹æŠ¥é“# è§†é¢‘æ¥æº:å¤®5 ä½“å›å¿«è®¯ç½‘é¡µé“¾æ¥ æŸ¯æ´ä¹æ®µæ–°é—»æ¬è¿å·çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u2driea/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#è¥¿å—æ£‹ç‹èµ›#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containe">https://m.weibo.cn/search?containe</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U3c2VEO">æŸ¯æ´#è¥¿å—æ£‹ç‹èµ›##èµ›äº‹æŠ¥é“# è§†é¢‘æ¥æº:å¤®5 ä½“è‚²æ–°é—»ç½‘é¡µé“¾æ¥ æŸ¯æ´ä¹æ®µæ–°é—»æ¬è¿å·çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u3c2veo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#è¥¿å—æ£‹ç‹èµ›#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?container">https://m.weibo.cn/search?container</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U3L3SDC">æŸ¯æ´#é›…å±…ä¹æ¸…æ°´æ¹¾æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›äº‹æŠ¥é“# è§†é¢‘æ¥æº:å¤®5 ä½“å›å¿«è®¯ç½‘é¡µé“¾æ¥ æŸ¯æ´ä¹æ®µæ–°é—»æ¬è¿å·çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u3l3sdc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O6U4ebht0">æŸ¯æ´#é›…å±…ä¹æ¸…æ°´æ¹¾æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›äº‹æŠ¥é“# è§†é¢‘æ¥æº:å¤®5 ä½“è‚²æ–°é—»ç½‘é¡µé“¾æ¥ æŸ¯æ´ä¹æ®µæ–°é—»æ¬è¿å·çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-27</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o6u4ebht0/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extpa</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

